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Tudor domain containing protein 6 and its essential role in murine 
spermatogenesis 
 
Expression of the Tudor domain containing protein 6 (TDRD6), which is restricted to the 
male germ line, starts at day 16 of spermatogenesis, i.e. in pachytene spermatocytes. 
TDRD6 is a 250 kDa protein, which we recently found to be cleaved at the C-terminal end 
during germ cell development, resulting in a 230 kDa product. Neither is the process of 
cleavage itself nor are the functions of the two different forms known. The 230 kDa isoform 
is the most prominent form in round spermatids, where it localizes to the chromatoid body 
(CB), i.e. a single filamentous, perinuclear granule. One characteristic component of the 
CB is the RNA helicase MVH. CBs contain components of the microRNA (miRNA) 
pathway, including Piwi-interacting RNAs (piRNAs), as well as MIWI, MIWI2, and MILI, the 
mouse homologs of the Piwi proteins, which bind piRNAs and also act in transposon 
regulation. We showed that TDRD6 interacts with MIWI and MILI in vitro, and a direct 
interaction with MVH was shown before. To reveal the function of TDRD6, we generated 
Tdrd6-/- mice, which lack the protein. These mice are generally healthy but the males are 
sterile, due to the absence of mature spermatozoa. The most striking intracellular 
phenotype of Tdrd6-/- mice is the highly aberrant architecture of chromatoid bodies in 
round spermatids. Tdrd6-/- CBs appear as diffuse, disrupted, and less condensed 
structures. Their interior is largely missing, and only a “ghost”-like structure remains, 
expected to be significantly impaired in function. Other CB components like MVH, MIWI 
and MILI are expressed in Tdrd6-/- testes, but they cannot localize to the disrupted CBs. 
This suggests a role for TDRD6 in assembling the chromatoid body complex by recruiting 
other proteins. The CB is important for storage and translational regulation of mRNA, 
through interaction with miRNAs. In Tdrd6-deficient testes 10 % of all known murine 
miRNAs are differently expressed, whereas most of the mature miRNAs are up-regulated, 
indicating less turnover, and thus, accumulation of mature miRNAs. Since some precursor 
miRNAs are up-regulated as well, we assume, that TDRD6 affects miRNA transcription 
most likely by indirectly influencing transcriptional regulation of miRNA genes. In Tdrd6-/- 
mice an overall abnormal mRNA gene expression pattern was observed by microarray 
analyses. Of all mis-regulated genes 36 % are located to the centromer-proximal region of 
Chr 8, and 11 % are located to the distal end of Chr 1. This mis-regulation might be due to 
a common transcriptional regulation. The orthologous regions on the human 
chromosomes show altered chromosomal structures in many different carcinomas. If 
TDRD6 plays a role in carcinogenesis has to be investigated. 
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1.  Introduction 
 
1.1.  Spermatogenesis 
 
Spermatogenesis in mice takes places in the seminiferous tubules of the testis, 
initiates a few days after birth and continues for the duration of the reproductive life of 
the animal. Spermatogenesis takes approximate 35 days and consists of the mitotic 
proliferation of spermatogonial cells, meiosis and spermiogenesis, the haploid 
spermatid differentiation stage (Braun 1998). The mammalian testis contains two 
discrete morphological compartments, interstitial tissue and the seminiferous tubules. 
Interstitial tissue is composed primarily of vascular, lymphatic and connective tissue 
elements, macrophages, fibroblasts and the androgen secreting interstitial cells of 
Leydig (Bellve et al. 1977). Within the seminiferous epithelium of the testis, 
developing germ cells and Sertoli cells are in close association with each other. The 
proliferation of spermatogonia occurs in the basal compartment of the seminiferous 
epithelium below the Sertoli junctional complexes (Dym and Fawcett 1970)       
(figure 1.1). 
 
Figure 1.1: Scheme of the testis structure and a cross section of a seminiferous tubule (Gilbert 
2000). Diploid spermatogonia reside in the basal compartment of the seminiferous tubule; divide 
mitotically to produce two diploid primary spermatocytes. Each spermatocyte then moves into the 
adluminal compartment of the tubule and duplicates its DNA and subsequently undergoes meiosis I to 
produce two haploid secondary spermatocytes. These spermatocytes undergo a second meiotic 
division to result in haploid round spermatids. The round spermatids go through several differentiation 
steps and culminate in elongated spermatids and mature spermatozoa, which are released into the 
lumen of the tubule.  
 
Introduction  4    
                         
Spermatogonia originate from primordial germ cells (PGCs). In the mouse, PGCs 
appear at the same time as the three embryonic layers: endoderm, mesoderm and 
ectoderm. PGCs are visible around 7 days post coitum (dpc) in the extra-embryonic 
mesoderm. They enter the developing fetal gonad, the genital ridge, at 9.5-11 dpc 
(Anderson et al. 2000). The testis structure is established while the PGCs proliferate 
and differentiate into prospermatogonia or gonocytes, which arrest in the G0/G1 
phase until 2 days after birth (18 dpc). By day 6 postpartum (dpp), these cells migrate 
to the basement membrane of the seminiferous tubules and become undifferentiated 
type A spermatogonia, the male germ line stem cells (GSCs) (McLaren 2000). Type 
A spermatogonia either renew themselves to maintain the pool of stem cells or 
undergo differentiation to produce spermatozoa (Dym 1994; Feng et al. 2002; 
Lacham-Kaplan 2004). Spermatogonia differentiate into spermatocytes, which 
undergo meiosis to produce haploid round spermatids. During mammalian meiosis, 
homologous chromosomes align, physically associated via formation of the 
synaptonemal complex (SC). The SC consists of two axial elements (AE), each AE 
supports the two sister chromatids of one homologue, which are connected by 
transverse filaments. Meiotic prophase I can be classified into four sequential 
substages defined by the development of the SC. Chromosome cores appear in 
leptotene and synapse during zygotene to form the SC. This assembly is completed 
by pachytene. In diplotene, the two homologues pull apart until they are held together 
only at the sites of crossing-over/chiasmata (Marcon et al. 2008). After the first 
meiotic division primary spermatocytes (4n) become secondary spermatocytes (2n), 
which undergo a second meiotic division. The resulting haploid round spermatids 
(1n) undertake drastic morphological changes via a process called spermiogenesis to 
become motile sperm (Unhavaithaya et al. 2009). Spermiogenesis in mouse is 
roughly divided into processes occurring in round spermatids (step 1-8) and those 
occurring in elongating spermatids (step 9-16) (Russell 1990) (figure 1.2). In round 
spermatids, the acrosome starts to differentiate (Kierszenbaum and Tres 1975). The 
acrosomal vesicle, a cap-like structure derived from the Golgi apparatus, is an 
organelle that stretches out around the anterior half of the sperm’s head. At later 
steps, the mitochondria become arranged in a spiral around the base of the 
flagellum, the future tail of the spermatozoa, and the nuclei become elongated, dense 
and compact (Saade et al. 2007). Spermiogenesis culminates with excision of the 
residual body and release of the spermatozoa into the lumen of the tubules. The 
Introduction  5    
                         
complexity of the seminiferous epithelium is compounded by the fact that cytokinesis 
is not completed at each of the successive mitotic and meiotic divisions. Thus, germ 
cells at comparable stages of differentiation exist as a syncytium in which many cells 
are interconnected by cytoplasmic bridges (Bellve et al. 1977). 
 
 
Figure 1.2: The cycle of the seminiferous epithelium (Russell 1990). The vertical columns, 
designated by Roman numerals (I-XII), depict cell associations (stages). A cycle is a complete series 
of cell associations, which are placed in logical order. The developmental progression of a cell is 
followed horizontally until the right hand border of the cycle map is reached. It continues at the left of 
the cycle map one row up. The cycle map ends with the completion of spermiation. Cell progression is 
divided into 16 steps, based on the form and shape of the acrosome, spermatid head shape and 
degree of chromatin condensation. The symbols used designate specific phases of cell development 
(In, intermediate spermatogonia; B, type B spermatogonia; Pl, preleptotene; L, leptotene; Z zygotene; 
P, pachytene; Di, diplotene; II, meiosis II). 
 
 
Coincident with the onset of meiosis, however, the early primary spermatocytes 
traverse the existing Sertoli junctions and enter the adluminal compartment. As 
differentiation proceeds, the spermatocytes and early spermatids are gradually 
displaced toward the lumen of the seminiferous tubule until, during late 
spermiogenesis, the spermatids lie within deep infoldings in the apical cytoplasm of 
the Sertoli cell (Bellve et al. 1977). Sertoli cells produce many soluble factors 
necessary for germ cell survival and proliferation, such as stem cell factor (SCF), 
basic fibroblast growth factor (bFGF), and leukaemia inhibitory factor (LIF) (Hofmann 
et al. 2003). 
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1.2.  Chromatoid Body  
 
Germ cells of various organisms are characterized by the accumulation of dense 
material into a cytoplasmic structure called germ plasm or nuage. In non-mammalian 
organisms, such as Drosophila melanogaster and Caenorhabditis elegans, germ 
plasm forms in a particular cytoplasmic region within the oocyte and, after fertilization 
of the egg, has an essential function in the specification of germ line lineage and the 
initiation of embryonic development (Ikenishi 1998). No germ plasm-like structure is 
detectable in unfertilized and fertilized eggs in mice (Nagamori and Sassone-Corsi 
2008). Nuage in mammalian spermatogonia, spermatocytes and oocytes is seen 
among clusters of mitochondria and is called “intermitochondrial cement”, whereas in 
spermatocytes and spermatids, larger solitary aggregates of nuage, termed 
“chromatoid bodies” (CB), are prominent in the cytoplasm (Hosokawa et al. 2007). 
On the basis of structural features and protein composition, the chromatoid body in 
the cytoplasm of mouse haploid male germ cells has been suggested to be the 
mammalian counterpart of germ plasm. The CB is composed of thin filaments that 
are consolidated into a compact mass or into dense strands of varying thickness that 
branch to form an irregular network. In the mouse, the CB appears for the first time in 
the cytoplasm of meiotic pachytene spermatocytes as a fibrous-granular structure 
(Parvinen 2005) (figure 1.3). After meiosis, the CB condenses into one single finely 
filamentous, lobulated, perinuclear granule in round spermatids and remains a 
distinctive feature in the cytoplasm of post-meiotic spermatids until the nucleus 
begins to elongate (Kotaja and Sassone-Corsi 2007). Although the chromatoid body 
in spermatogenesis was described more than 100 years ago (Brenda 1891), its 
origin, function, chemical composition, and fate is still controversial (Parvinen and 
Jokelainen 1974). The varying localization of the CB during successive stages of 
spermatogenesis is one of its primary features. The CB moves rapidly in the 
cytoplasm of spermatids in both parallel and perpendicular fashion related to the 
nuclear envelop (Parvinen and Parvinen 1979). Actin is a possible motor of this 
movement, together with a calcium-cAMP dependent mechanism and cytoplasmic 
microtubules (Parvinen 2005). During this movement the CB has been suggested to 
collect gene products from the nucleus, and to be involved in nucleocytoplasmic RNA 
transport (Parvinen 2005). The testis-specific kinesin KIF17b has been shown to 
shuttle between the nucleus and the chromatoid body and thus, provides a potential 
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mechanism for the active transport of material from one compartment to the other 
(Kotaja et al. 2006b). The CB was also reported to move through cytoplasmic bridges 
to neighbouring cells, suggesting that this organelle could provide a mechanism to 
share haploid products between adjacent spermatids (Ventela et al. 2003).  
 
 
c 
 
 
Figure 1.3: The CB is a dense fibrous structure in the cytoplasm of haploid round spermatids 
(Kotaja and Sassone-Corsi 2007). (a) For light microscopy, mouse germ cells of early stage II of the 
seminiferous epithelial cycle, were observed under phase-contrast optics. The CB is shown as a 
single dense granule that is in close contact with the nuclear envelope in the cytoplasm of round 
spermatids. (b) Electron microscopy was carried out with seminiferous tubule segments from stages I-
IV. The CB seems to be composed of thin filaments that are consolidated into dense strands of 
varying thickness that branch to form an irregular network. (c) Schematic representation of 
transcriptional activity and appearance of the CB during spermatogenesis. CB material is first 
apparent in late pachytene spermatocytes prior to the first meiotic division as intermitochondrial 
cement, fibrous structures that disperse during meiotic division. The CB is condensed to its final shape 
immediately after meiosis, and remains a distinctive feature in the cytoplasm of post-meiotic round 
spermatids next to the nucleus. It diminishes in size and then disappears in elongating spermatids. D, 
diplotene; L, leptotene; P, pachytene; PL, preleptotene; Z zygotene.  
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Studies on the molecular composition of the CB provide an attractive experimental 
gateway for the understanding of the physiological role played by this organelle 
(Nagamori and Sassone-Corsi 2008). It has been recently shown that microRNA 
(miRNA) pathway components, such as the miRNA-processing endonuclease 
DICER, Argonaute proteins, and miRNAs are concentrated in CBs (Kotaja et al. 
2005; Kotaja et al. 2006a). Additionally, components of RNA processing bodies      
(P-bodies) accumulate in CBs indicating that the germ cell-specific CBs and somatic 
P-bodies are functionally related (Kotaja et al. 2006a). As P-bodies in somatic cells 
are thought to integrate RNA decay and regulation by miRNAs, it was proposed that 
CBs function as platforms for miRNA pathways in germ cells (Kotaja et al. 2005). 
These notions strengthen the hypothesis of RNA interference and miRNA pathways 
being mechanisms essential for gene regulation in spermatogenesis (Nagamori and 
Sassone-Corsi 2008). 
Poly(A)-containing mRNAs accumulate in the CBs of spermatids and have suggested 
that the process of translational repression is organized within this cytoplasmic 
structure (Kotaja et al. 2006a). This hypothesis was supported by the finding of the 
cytoplasmic poly(A)-binding protein 2 (PABPC2) in the chromatoid body of 
spermatids (Kimura et al. 2009), which is involved in translational initiation, 
translation termination, and mRNA decay (Mangus et al. 2003; Kuhn and Wahle 
2004).  
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1.3.   Chromatoid body components 
 
1.3.1. Tudor domain family proteins 
 
Genetic studies in Drosophila have identified numerous genes (i.e., Oskar, Vasa, 
Nanos, Tudor) that are involved in the formation of germ cell precursors and pole 
cells (Rongo and Lehmann 1996). One of these components of Drosophila nuages is 
Tudor, which is genetically downstream of Vasa (Golumbeski et al. 1991; Bardsley et 
al. 1993). One characteristic of the TUDOR protein is the presence of ten repeated 
copies of the tudor domain (Ponting 1997). Tudor domains are related to plant 
Agenet, Chromo PWWP (conserved Proline and Tryptophane), and MBT (malignant 
brain tumour) domains, which together form the tudor domain “Royal Family” 
(Maurer-Stroh et al. 2003). The tudor domain is about 60 amino acids long and was 
initially found in proteins that associate with nucleic acids (Ponting 1997). Three-
dimensional analysis of the domain reveals a barrel-like structure composed of ß-
sheets forming a hydrophobic pocket surrounded by negatively charged residues that 
most likely constitutes a protein-protein interaction surface (Ponting 1997; Selenko et 
al. 2001; Huyen et al. 2004). A scaffolding function has also been suggested, 
allowing the assembly of cellular proteins that associate with each tudor domain into 
macromolecular complexes (Hosokawa et al. 2007; Skorokhod et al. 2008).  
Tudor domain proteins have been shown to interact with other proteins and efficient 
binding requires methylated arginine and lysine residues in the target protein 
(Brahms et al. 2001; Huyen et al. 2004; Cote and Richard 2005; Kim et al. 2006); 
(Sprangers et al. 2003). The tudor domain of the Survival motor neuron (SMN) 
protein binds directly to spliceosomal assembly (Buhler et al. 1999; Brahms et al. 
2001; Selenko et al. 2001; Sprangers et al. 2003). It has been shown, that this 
domain directly binds the arginine-glycine rich tail of the SMN proteins in vitro (Buhler 
et al. 1999; Selenko et al. 2001). A number of tudor domain proteins, like the 53 
Binding Protein 1 (53BP1), have been shown to interact with modified histone H3 on 
methylated Lys79 (Huyen et al. 2004). Several of the first tudor domain containing 
proteins that were identified, have well known RNA binding motifs. Based on this 
knowledge, it was suggested that tudor domains may have a role in RNA metabolism 
(Ponting 1997).  
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Several tudor domain containing proteins exist in mammalian germ cells, including 
TDRD1, TDRD2, TDRD3, TDRD4, TDRD5, TDRD6, TDRD7 and TDRD9.  
Tudor domain containing protein 1/ mouse tudor repeat 1 (Tdrd1/Mtr-1) is a Tudor-
related gene in mice (Wang and Dreyfuss 2001; Chuma et al. 2003). TDRD1 
contains four tudor domains and a zinc finger MYND domain. TDRD1 expression 
starts in pachytene spermatocytes and stops in round spermatids (Hosokawa et al. 
2007) (figure 1.4). TDRD1 expression is confined to male germ cells, and this protein 
constitutes the chromatoid bodies in round spermatids (Chuma et al. 2003). Tdrd1 
mutant mice lack intermitochondrial cement, but chromatoid bodies are visible. The 
male mutant mice are sterile and the females are not affected (Chuma et al. 2006). 
TDRD3 is expressed in various tissues and plays a role in stress granules (Linder et 
al. 2008). With its single tudor domain it is able to bind methylated proteins (Cote and 
Richard 2005). TDRD4, also called RNF17, is restricted to the male germline and 
Rnf17-deficient mice are sterile. The protein is localized to the so-called RNF17 
granule, another form of nuage in the cytoplasm of male germ cells. It has five tudor 
domains and it is expressed in pachytene and diplotene spermatocytes. In round 
spermatids its expression is restricted to step 10 and later spermatids (figure 1.4) 
(Pan et al. 2005). TDRD5 has one tudor domain and is a germ line-specific protein in 
mouse, which expression starts around 12.5 days post coitum and continues 
throughout testis development (figure 1.4). About the function of this tudor domain 
protein nothing is known (Smith et al. 2004). TDRD7/TRAP (tudor repeat associator 
with PCTAIRE 2) contains four tudor domains, it is localized to the CB and forms a 
complex with TDRD1 and TDRD6 (Hirose et al. 2000; Hosokawa et al. 2007). 
TDRD7 expression starts in early-pachytene spermatocytes, and in mid-late 
pachytene spermatocytes, the signal exhibits fine granular appearance. In 
spermatids, TDRD7 forms larger solitary aggregates similarly to TDRD1 and TDRD6, 
corresponding to the chromatoid bodies (figure 1.4) (Hosokawa et al. 2007). So far 
nothing is known about expression, localization and function of TDRD2, TDRD8 and 
TDRD9 in germ cells.  
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Figure 1.4: A scheme of spermatogenesis is shown with the timing of expression of MILI, MVH, 
MIWI2, MIWI, MAEL, TDRD1, TDRD4, TDRD5, TDRD6 and TDRD7. After migration, primordial germ 
cells (PGCs) arrive at the gonad around 11.5 dpc and expand prior to undergoing cell-cycle arrest at 
15.5 dpc. Germ cells resume division after birth at around 3 dpp and initiate meiotic division at 10 dpp. 
The first haploid round spermatids appear at day 20 after birth.  
 
 
TDRD6 has seven of the characteristic tudor domains. It is the closest homolog of 
Drosophila Tudor (Vasileva et al. 2009). The human TDRD6 was initially identified as 
a tumour-dependent antigene present in serum of colon carcinoma patients, called 
NY-CO-45 (Scanlan et al. 2002). In primary cells, it is specifically expressed in germ 
cells (Hosokawa et al. 2007) and  appears first in primary late spermatocytes (17.5 
dpp) as multiple fine filamentous cytoplasmic granules. In postmeiotic round 
spermatids at 20.5 dpp, the TDRD6 signal appears as bright, distinct perinuclear dots 
(figure 1.4). TDRD6 was not detected in female mice (Vasileva et al. 2009). TDRD6 
(2134 aa) was reported to migrate as a 250 kDa protein in SDS gel electrophoresis 
(Hosokawa et al. 2007). Whereas in the extracts from mice aged 17 dpp, the 
expected 250 kDa TDRD6 protein was detected, extracts from older mice display a 
strong band of 230 kDa and a weak band of 250 kDa. Mass spectrometric analysis of 
the two immunoprecipitated proteins confirmed that both are products of the Tdrd6 
gene (Vasileva et al. 2009). There is no indication for alternative splice products from 
our and other studies (Hosokawa et al. 2007; Vasileva et al. 2009).   
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1.3.2. Mouse Vasa homolog 
 
Another component of Drosophila nuage is VASA. It is a member of the DEAD-box 
family of genes encoding an ATP-dependent RNA helicase. VASA is required for the 
assembly and function of the pole plasm in Drosophila (Lasko and Ashburner 1988) 
(Liang et al. 1994). In addition, on the basis of structural conservation, genes 
homologous to Vasa have been identified in many animal species, such as 
C.elegans, Xenopus, zebrafish and mouse (Roussell and Bennett 1993; Fujiwara et 
al. 1994; Komiya et al. 1994; Olsen et al. 1997; Yoon et al. 1997). The mouse vasa 
homolog (MVH) protein exhibits specific expression in developing germ cells 
(Fujiwara et al. 1994). The expression of MVH is maintained in both male and female 
germ cells ranging from PGCs of 12.5 dpc gonads to postmeiotic round spermatids 
and primary oocytes (Tanaka et al. 2000) (figure 1.4). Targeted mutation of the Mvh 
gene in the mouse yields a drastic interruption of spermatogenesis by the zygotene 
stage, before the formation of the CB (Tanaka et al. 2000). Oogenesis and formation 
of germ cells are not affected in Mvh-null mice, possibly underscoring the differences 
in the germ-cell-fate determination systems between fruit fly and mouse (Kotaja and 
Sassone-Corsi 2007).  
 
1.3.3. Piwi proteins 
 
As seen in other organisms, the expression of the three murine Piwi proteins, MIWI 
(PIWIL1), MILI (PIWIL2), and MIWI2 (PIWIL4), is largely germ line restricted 
(Kuramochi-Miyagawa et al. 2001; Sasaki et al. 2003). MILI is expressed from 12.5 
days post coitum until round spermatid stage (figure 1.4), at which point the majority 
of MILI localizes in the chromatoid body (Kuramochi-Miyagawa et al. 2001; Wang et 
al. 2009). MILI is not only expressed in spermatocytes and spermatogonia, but also 
in primordial germ cells of both sexes (Kuramochi-Miyagawa et al. 2001). 
Spermatogenesis in Mili-null mice was blocked completely at the early prophase of 
the first meiosis, from the zygotene to early pachytene stage, and the mice were 
sterile. However, PGC development and female germ cell production were not 
disturbed (Kuramochi-Miyagawa et al. 2004).  
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MIWI2 could be detected in male germ cells beginning around 14.5 – 15.5 dpc, but 
was absent from female germ cells as well as somatic cells and the embryonic 
gonads. MIWI2 expression declined soon after birth, reaching undetectable levels in 
4-day-old mice (figure 1.4) (Aravin et al. 2008). Miwi2-deficient mice display a 
meiotic-progression defect in early prophase of meiosis I and a progressive loss of 
germ cells with age (Carmell et al. 2007). 
MIWI is a cytoplasmic protein that is first detectable at 14 dpp, a stage that 
corresponds to the appearance of pachytene spermatocytes (Deng and Lin 2002). 
The MIWI protein is clearly detectable until step 13 elongating spermatids (figure 
1.4). MIWI is not detectable in Sertoli cells or interstitial cells. Miwi-null mice display 
spermatogenic arrest at the beginning of the round spermatid stage (Deng and Lin 
2002). 
Deficiency in either of two Piwi family members, MILI or MIWI2, leads to loss of DNA 
methylation marks on transposons and results in increase of transposition activity. 
These observations led to the hypothesis that Piwi proteins might serve as 
sequence-specific guides that direct the de novo DNA methylation machinery to 
transposable elements (Aravin et al. 2007; Aravin et al. 2008; Kuramochi-Miyagawa 
et al. 2008) 
 
1.3.4. Maelstrom 
 
In the Drosophila female germ line, maelstrom (MAEL) is found predominantly in 
nuage, but its function is unknown (Findley et al. 2003). MAEL contains a domain 
with similarity to a high mobility group (HMG) box DNA-binding domain. First MAEL 
expression was observed in the early stages of meiotic prophase I (leptotene to 
midpachytene). Round spermatids contain MAEL in the CB (figure 1.4). Mael-null 
mice show a meiotic arrest of spermatogenesis due to failure of chromosome 
synapsis, as well as derepression of transposable elements (TEs), like observed in 
MILI and MIWI2 mutant mice (Soper et al. 2008).  
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1.3.5. Interplay of chromatoid body components 
 
To find interacting partners of TDRD6 immunoprecipitation analyses were done by 
our group, using an antibody against the middle part of TDRD6 and total testis 
extract. MVH, MIWI and MILI as possible interaction partners were found. 
Additionally a direct interaction of MVH and TDRD6 was shown by (Hosokawa et al. 
2007), and an in vitro interaction of MIWI and MILI with TDRD6 was confirmed by our 
group (Vasileva et al. 2009).  
TDRD6 was found to form a ribonucleoprotein complex with TDRD1 and TDRD7 
(Hosokawa et al. 2007). In a mouse mutated in Mvh, TDRD6 and TDRD7 aberrantly 
localizes in cytoplasmic granules, indicating that MVH is required for proper 
localization of these two tudor domain proteins (Hosokawa et al. 2007).  
 
 
1.4.  Transcriptional regulation in spermatogenesis 
 
The complex and highly elaborated differentiation program of male germ cells 
involves multiple and finely tuned levels of gene control (Sassone-Corsi 2002). 
During late steps of spermiogenesis there is a striking cessation of transcription, 
occurring in concert with drastic epigenetic modifications that result in chromatin 
compaction (Kimmins and Sassone-Corsi 2005). Concomitantly there is an extensive 
posttranscriptional storing and processing of mRNAs (Steger 2001). One possibility 
to regulate gene expression is the involvement of small RNAs, which are known to 
function in several pathways for gene silencing. These non-coding RNAs, which are 
19-31 nucleotides long, behave as sequence-specific triggers for mRNA degradation, 
translational repression, heterochromatin formation, and transposon control (Chu and 
Rana 2007). Small RNAs can be classified into different groups based on their origin 
or the components to which they are coupled. The most abundant small RNA groups 
include microRNA (miRNA), small-interfering RNAs (siRNAs), repeat-associated 
siRNAs (rasiRNAs) and Piwi-interacting RNAs (piRNAs). MiRNAs and siRNAs 
facilitate translation repression in various organisms, by cleaving their target mRNAs. 
RasiRNAs are longer than siRNAs and silence repetitive and mobile genetic 
elements in yeast, plants, and flies (Aravin et al. 2001; Hamilton et al. 2002; Reinhart 
and Bartel 2002). Recent studies have shown that fly rasiRNAs are similar to the 
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mammalian piRNAs, which associate with germ line specific Piwi proteins to silence 
transposons during spermatogenesis (Chu and Rana 2007; O'Donnell and Boeke 
2007). For this thesis it will be focused mainly on miRNAs and piRNAs. 
 
1.4.1. microRNAs (miRNAs) 
 
Genes for miRNAs are located on all chromosomes, and half of all miRNAs are 
identified in clusters that can be transcribed as polycistronic primary transcripts. It 
has been shown that miRNAs located in the same genomic cluster, can be 
transcribed and regulated independently (Song and Wang 2008). MiRNA genes are 
found in introns of non-coding or coding genes and in exons on non-coding genes 
(Rodriguez et al. 2004). MiRNAs are transcribed by RNA polymerase II or III as 
precursor molecules with 5’ m7G capping structures and 3’ poly-A tails (Cai et al. 
2004; Lee et al. 2004). These long transcripts of primary miRNA genes (pri-miRNA) 
are subsequently cleaved by the complex Drosha-DGCR8 (DGCR8 is also known as 
Pasha in Drosophila and C.elegans) to produce a stem-loop structured precursor, the 
preliminary miRNA (pre-miRNA) which is ~ 70-nt long. After the first processing step 
in the nucleus, pre-miRNAs with a short hairpin structure are recognized by the 
nuclear export factor, Exportin-5 (EXP5), which delivers pre-miRNA through nuclear 
pores to the cytoplasm (Yi et al. 2003; Lund et al. 2004). Upon export, pre-miRNAs 
are then processed by DICER, a highly conserved, cytoplasmic RNase III, that chops 
long double stranded (ds) RNAs into ~ 22-nt duplexes of mature miRNAs (Kim et al. 
2009) (figure 1.5). 
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Figure 1.5: The canonical pathway of microRNA processing (Winter et al. 2009). This maturation 
includes the production of the primary miRNA transcript (pri-miRNA) by RNA polymerase II or III and 
cleavage by the complex Drosha-DGCR8 in the nucleus. The resulting preliminary (pre-) miRNA is 
exported from the nucleus by Exportin-5-Ran-GTP. In the CB, the RNase DICER in complex with 
TRBP cleaves the pre-miRNA hairpin to its mature length. The functional strand of the mature miRNA 
is loaded together with Argonaute (AGO2) proteins into the RNA-induced silencing complex (RISC), 
where it guides RISC to silence target mRNAs through mRNA cleavage, translational repression or 
deadenylation, whereas the passenger strand is degraded.  
 
 
Mature miRNAs are assembled into the miRISC (miRNA-induced silencing complex), 
which subsequently act on targets by translational repression or mRNA cleavage. 
During the RISC-loading stage, only one strand of the miRNA duplex is successfully 
incorporated into the RISC, while the other strand is eliminated. MiRISC contains 
several proteins such as DICER, the double-stranded RNA-binding protein TRBP 
(transactivation-response element RNA-binding protein), and Gemin3, but the 
components directly associated with miRNAs are Argonaute proteins, which were 
shown to be localized to the chromatoid body (Carmell et al. 2002; Kotaja et al. 
2006b). These proteins share the so-called PAZ and PIWI domains and are classified 
into two subfamilies depending on sequence similarity to either Arabidopsis 
Argonaute 1 or Drosophila Piwi (Carmell et al. 2002; Sasaki et al. 2003). In 
mammals, Argonaute 1 subfamily members, AGO1 to AGO4, have been shown to be 
involved in the RNAi/miRNA pathways (Liu et al. 2004; Meister et al. 2004; Kotaja et 
al. 2006a). A general feature of the miRNA-target RNA interaction is imperfect base 
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pairing between the miRNA and its target mRNA. The sequence specificity for target 
recognition by the guide miRNA strand is determined by nucleotides 2-8 of its 5’ 
region, referred to as the “seed sequence” (Carthew and Sontheimer 2009).  
At least three mechanisms are supported for miRNA-mediated gene silencing (Chu 
and Rana 2007; Winter et al. 2009). The first model is, that both cap- and internal 
ribosome entry site (IRES)-dependent protein synthesis from the polycistronic 
reporter construct can be repressed by miRNA and these translational repressed 
mRNAs are associated with polysomes (Petersen et al. 2006). The second model is, 
that translational repression is mediated by binding of the Ago protein of the RISC to 
the mRNA cap structure (Kiriakidou et al. 2007). These observations support a 
mechanism where Ago competes with eIF4E (eukaryotic initiation factor 4 E) for cap-
binding and suppress translation (Chu and Rana 2007). The third model is, that 
miRNAs could trigger destabilization of target mRNA by a deadenylation mechanism 
(Behm-Ansmant et al. 2006; Wu et al. 2006).  
Given the complexity of miRISC structure and function, it is tempting to propose that 
these mechanisms of gene silencing by miRNA take place simultaneously or perhaps 
synergistically (Winter et al. 2009).  
 
1.4.2. Piwi-interacting RNAs (piRNAs) 
 
Not all Argonaute proteins in Drosophila and mammals are ubiquitously expressed. 
One group of these proteins, PIWI, is the germ line-specific subclass of Argonaute 
proteins. The Piwi family genes encode basic proteins that contain a highly 
conserved PAZ domain of 110-amino acid residues in the middle region of the 
proteins and a 300-amino acid PIWI domain in the C-terminal region (Kuramochi-
Miyagawa et al. 2004). Mammalian Piwi proteins were reported to interact with a new 
class of RNAs that were longer than miRNAs (Aravin et al. 2006; Girard et al. 2006). 
These Piwi-interacting RNAs are called piRNAs. Like other members of the Ago 
family, Piwi proteins associate with small RNAs that act as guides in silencing target 
mRNA. Sequence analysis of piRNAs shows a high percentage of uridine residues at 
the 5’ termini (Faehnle and Joshua-Tor 2007), and genomic mapping shows that 
piRNAs are concentrated at a few loci. Primary piRNAs are generated from 
dedicated loci, called piRNA clusters, which contain a high density of transposon-
related sequences (Brennecke et al. 2007). Primary piRNAs join Piwi proteins and 
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guide these to the selection of their targets. Two outcomes follow recognition of a 
transposon mRNA by a piRNA. First, the mRNA is cleaved, resulting in its 
destruction. The cleavage event also promotes the production of a secondary piRNA 
derived from the mRNA itself (Brennecke et al. 2007; Gunawardane et al. 2007). 
Though this is in the sense orientation with respect to the transposon, it can target 
antisense piRNAs that can again target transposons. As a whole, this creates a so- 
called “ping-pong cycle” that optimizes the piRNA population to target active 
elements (Brennecke et al. 2007; Aravin et al. 2008). 
 
 
1.5.  Transposons 
 
Mammalian transposable elements consist of DNA transposons and 
retrotransposons. DNA transposons move by a “cut and paste” mechanism utilizing 
transposase (Mizuuchi 1992; Smit and Riggs 1996). Although roughly 3 % of the 
human genome is composed of DNA transposons, they are remnants of ancient 
elements, and it is unlikely that any remain transpositionally active. In contrast to 
DNA transposons, retrotransposons encode a reverse transcriptase (RT) activity and 
move by a “copy and paste” process involving an RNA intermediate. The original 
retrotransposon is maintained in situ where it is transcribed. The transcript is then 
reverse transcribed and integrated into a new genomic location (Whitcomb and 
Hughes 1992; Luan and Eickbush 1995). Approximately 42 % of the human genome 
is composed of retrotransposons, and, although most of these elements are inactive, 
some retain the ability to retrotranspose (Sassaman et al. 1997). Retrotransposable 
elements can be classified as either autonomous or nonautonomous. Elements are 
considered autonomous if they encode certain activities necessary for their mobility. 
There are two classes of autonomous retrotransposons: LTR (long terminal repeat) 
and non-LTR retrotransposons. Mammalian LTR retrotransposons are structurally 
similar to retroviruses. These retrotransposons include elements such as mouse 
intracisternal A-particle (IAPs). The non-LTR retrotransposon class contains LINEs 
(long interspersed nucleotide elements), like LINE-1 in mice (Malik et al. 1999; Smit 
1999). In addition to the autonomous retrotransposons, there are a large number of 
nonautonomous retrotransposons in mammalian genomes. These elements do not 
encode any proteins. Therefore, they require activities encoded by other autonomous 
retrotransposons for their mobility. The most prominent members of this class are Alu 
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elements in humans and their B1 counterpart in mice (Rowold and Herrera 2000; 
Ostertag and Kazazian 2001). Non-LTR retrotransposons usually have two open 
reading frames (ORFs), one encoding a nucleic acid binding protein, and the other 
encoding an endonuclease and a reverse transcriptase. Mammalian LINE-1 
elements apparently integrate at a very large number of sites in the genome because 
their endonuclease prefers to cleave DNA at a short consensus sequence (5’-
TTTT/A-3’, where / designates the cleavage site) (Feng et al. 1996; Jurka 1997).  
Epigenetic stable repression of transposable elements in mammals requires CpG 
DNA methylation (Walsh et al. 1998; Bourc'his and Bestor 2004). Transposon 
methylation patterns are extensively remodelled during mammalian development. 
Following fertilization, gametic methylation patterns are mostly lost (Lane et al. 2003). 
De novo methylation patterns are then established around implantation and 
subsequently maintained in somatic cells throughout the life of the organism. The 
germ line undergoes a wave of transposon demethylation soon after its emergence 
during embryogenesis (Hajkova et al. 2002). In males, after migrations of primordial 
germ cells into embryonic gonads and their initial expansion, germ cells arrest their 
cell cycle around 14.5 days post coitum (dpc) as spermatogonia, only resuming 
division 2-3 days after birth (dpp). This is the critical window during which male 
gametic methylation patterns are established (Lees-Murdock et al. 2003; Kato et al. 
2007). Several members of the DNA methyltransferase family, DNMT3A, DNMT3B, 
and DNMT3L, act in de novo methylation of transposable elements. DNMT3A and 
DNMT3B are important in both germ and somatic cells. DNMT3L operated as a 
central regulator of de novo methylation specifically in the germ line. Recent studies 
have begun to unravel the biochemistry of de novo DNA methylation, which might be 
preceded by specific histone modifications (Jia et al. 2007; Ooi et al. 2007), but it is 
still not clear how transposon sequences are specifically recognized to receive such 
modifications. In the male germ line, deficiency in either of two Piwi family members, 
MILI or MIWI2, results in loss of the DNA methylation marks on transposons, and 
mutant animals display a phenotype remarkably similar to that of Dnmt3L-deficient 
mice, a globally failure to establish de novo methylation of transposons in their germ 
cells (Kuramochi-Miyagawa et al. 2004; Carmell et al. 2007; Aravin et al. 2008; 
Kuramochi-Miyagawa et al. 2008). These data led to the hypothesis that Piwi/piRNA 
complexes might serve as sequence-specific guides that direct the de novo DNA 
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methylation machinery to transposable elements (Aravin and Bourc'his 2008; 
Kuramochi-Miyagawa et al. 2008) 
 
 
1.6.  Aims and structure of this thesis 
 
Aim of this thesis was to investigate and understand the role of TDRD6 in 
spermatogenesis in mice. Since it is a male germ line restricted protein in various 
organisms, we suggested that it might play an important role in germ cell 
development. Until now, not so many details about expression pattern and function of 
TDRD6 are known. To get first information about the function of this protein, a Tdrd6-
deficient mouse model was generated. Several phenotypic analyses were carried 
out, e.g. examination of the organization and shape of the chromatoid body. 
Furthermore other major components of the chromatoid body were investigated, if 
they were modified in the Tdrd6-deficient mouse. For instance other known proteins, 
that localize to the CB, components of the miRNA pathway and variation in 
transposon activity. Whole genome microarray analyses were done, to get 
information about modified gene expression in the Tdrd6-deficient mouse. 
To get knowledge about differently localization of the two existing isoforms of 
TDRD6, antibodies specific for each terminus of the protein were generated.  
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2. Material and Methods 
 
2.1. Construction of a Tdrd6-deficient mouse model 
 
To generate the tdrd6null allele the first of five exons was disrupted (ENSEMBLE gene 
ID ENSMUSG00000040140), which contains 95% of the Tdrd6 cDNA sequence. 
Homologous genomic sequences amplified by PCR (Table 2.4) were cloned into the 
targeting vector pTV-Uni (Gadue et al. 2006) (Figure 2.1). This plasmid was kindly 
provided by A. Vasileva (MSSM, NY). The final targeting vector consisted of: (i) the 
Diphtheria toxin A gene (Dta) for negative selection; (ii) a 5' “short arm” of homology 
encompassing 1.4 kb upstream of the start codon; (iii) a truncated human CD4 
cDNA; (iv) a loxP flanked puromycin resistance gene; and (v) a "long arm" of 
homology encompassing 5 kb downstream of exon 1 of the Tdrd6 locus.  
 
 
 
Figure 2.1: Targeting vector pTV-KO-Tdrd6. 
 
 
The production of targeted embryonic stem (ES) cells clones was performed in 
accordance with standard procedures (Joyner 2000). Briefly, the targeting vector was 
linearized by digestion with PvuI and was electroporated into 129SvEv embryonic 
stem cells (Taconic Inc.). After selection with 0.75 µg/ml puromycin, 300 drug-
resistant clones were picked and cultured separately in replica. Whereas clones in 
one of the replica plates were cultured further on, the other replica plate was used for 
isolation of DNA. Positive clones were identified by PCR (Table 2.4) and absence of 
random integration was confirmed by Southern Blotting. One positive clone was 
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found and the respective clone from the replica plate was injected into a C57BL/6 
blastocyst. The resulting chimeras were crossed with C56BL/6 mice.  
 
 
2.2. Generation of TDRD6 specific antibodies 
 
Two Tdrd6 cDNA fragments encompassing amino acid residues 52-171 (TDRD6-
Nterm) and 2058-2182 (TDRD6-Cterm) were subcloned into the Escherichia coli 
expression vector pGEX-4T-3 (Invitrogen) (figure 2.2 and table 2.4). These plasmids 
were kindly provided by A. Vasileva (MSSM, NY).  
 
 
 
Figure 2.2: Expression vector pGEX with TDRD6-Cterm and -Nterm peptides for antibody 
production, respectively. 
 
 
The GST-tagged peptides TDRD6-Nterm and TDRD6-Cterm were overexpressed in 
Stbl2TM competent cells (Invitrogen) by induction with IPTG and purified on 
glutathione agarose. The TDRD6-Cterm was eluted with 30 mM glutathione, the 
TDRD6-Nterm was insoluble under native conditions and was solubilized in 6 M urea. 
After dialyzing against dialyzing buffer I, the peptides were used for immunization. 
100 µg peptide (total volume 500 µl, filled up with PBS) were mixed with 500 µl of 
Freund’s complete adjuvants and injected into two rabbits for each peptide. Table 2.1 
shows the numeration of the used rabbits. 
 
Rabbit numeration Peptide 
#27477 TDRD6-Cterm No. 1 
#27507 TDRD6-Cterm No. 2 
#27459 TDRD6-Nterm No. 1 
#27515 TDRD6-Nterm No. 2 
Table 2.1: Number of rabbits and corresponding peptides. 
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The initial immunization was followed by series of bleedings and injections with the 
according peptide mixed with an equal volume of Freund’s incomplete adjuvants. The 
injections were repeated every four weeks and in addition 20 ml blood was drawn 
from ear vessels. After coagulation of the blood, the serum was separated by 
centrifugation and stored at -20 °C. The obtained sera were purified with Protein A-
agarose. In detail, the serum was mixed 1:10 with PBS-T and applied to a Poly-Prep® 
Chromatography column (Bio-Rad) filled with 500 µl Protein A-agarose. After 
washing with 10 ml of 100 mM Tris pH 8.0 and 10 ml of 10 mM Tris pH 8.0, the 
antibodies were eluted with 10 ml of 100 mM Glycine pH 2.9. Fractions of 1 ml were 
collected in tubes filled with 100 µl of 1 M Tris pH 8.0 for neutralization. After 
examining the fractions by sodium dodecylsulfate polyacrylamide gel electro-
phoresis (SDS-PAGE), the fractions containing antibodies were pooled and dialyzed 
against 500 ml dialyzing buffer I. Concentrations were measured using a 
spectrophotometer and the antibodies were stored in aliquots at -20°C. 
The TDRD6-Cterm serum was additionally purified using Cyanogen bromide-
activated-Sepharose coupled to the TDRD6-Cterm peptide. In detail, after 
overexpression of the TDRD6-Cterm peptide, it was dialyzed against buffer II 
overnight. The Cyanogen bromide-activated-Sepharose beads were solved in 1 mM 
HCl and washed with the same solution. The peptide and the beads were mixed and 
incubated overnight on a rotating wheel at 4°C. The binding efficiency was measured 
by comparing the optical dense of the supernatant before and after incubation. A 
binding efficiency of 50 % was achieved. The beads were washed twice with wash 
buffer I, and once with wash buffer II. The remaining active groups were blocked with 
100 mM Tris pH 8.0 overnight at 4 °C. After washing the beads with PBS, they were 
filled in a Poly-Prep® Chromatography column (Bio-Rad) and washed with each 10 
vol of 10 mM Tris pH 7.5, 100 mM Glycine pH 2.9, 10 mM Tris pH 8.8, 100 mM Tris 
pH 11.5. To neutralize the beads, they were washed with 10 mM Tris pH 7.5 until the 
pH reaches 7.5. Before loading the rabbit serum to the beads it was diluted 1:10 with 
10 mM Tris pH 7.5. Sodium azide to a final vol of 0.1 % was added to avoid growing 
of bacteria. After applying the serum very slowly to the beads, they were washed with 
20 vol 10 mM Tris pH 7.5 and 20 vol 0.5 M NaCl, 10 mM Tris pH 7.5. Antibodies 
were eluted with 10 vol 100 mM Glycine pH 2.9 and 1 ml fractions were collected in 
tubes filled with 100 µl 1 M Tris pH 8.0 for neutralization. After washing the beads 
with 10 mM Tris pH 8.8, the remaining antibodies were eluted by adding 10 vol of 
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100 mM Tris pH 11.5 and fractions were collected like described before. The 
fractions were examined by SDS-PAGE, pooled and dialyzed against buffer I 
overnight. The antibodies were stored in aliquots at -20°C. After washing the beads 
with 10 mM Tris pH 7.5, the column can be stored by applying PBS with proteinase 
inhibitors and 0.1 % sodium azide at 4°C.   
 
 
PBS (Phosphate Buffered Saline)  137 mM NaCl, 2.7 mM KCl, 100 mM Na2HPO4,  
     2 mM KH2PO4 
Dialyzing buffer I    PBS, 10 % glycerol, proteinase inhibitors 
Dialyzing buffer II    PBS, 0.05 M Na2HPO4, 0.5 M NaCl, pH 8.3   
PBS-T     PBS, 0.1 % Tween-20 
Proteinase Inhibitors   0.5 mM vanadate, 2 mM PMSF, 10 mM Na2S2O5, 50 µg/ml 
     TLCK, Complete (Roche) 
Wash buffer I     0.5 M Na2HPO4 pH 8.0 
Wash buffer II    1 M NaCl, 0.05 M Na2HPO4   pH 7.5 
 
 
2.3. Periodic acid-Schiff/Hematoxylin staining 
 
Testes were dissected and fixed in Bouin’s solution overnight at 4°C, washed in 70 % 
ethanol for 24h and embedded in paraffin. Testes were cut into 7 µm sections and 
deparaffinized using standard xylene/ethanol procedures. In detail, slides were 
placed 2 times for 10 min each in xylene, 99 % Ethanol, 96 % Ethanol and 70 % 
Ethanol. Finally the slides were washed with distilled water and placed in 0.5 % 
periodic acid for 5 min. After washing the slides in 3 changes of water, they were 
incubated in Schiff’s reagent for 15 min. Slides were incubated 2 x with 0.55 % 
Potassium metabisulfite for 1 min to remove excess reagent and washed in running 
tap water for 10 min to allow the color to develop. After counterstaining with acidified 
Harris Hematoxylin for 10 sec, slides were dehydrated using 96 % Ethanol, 99 % 
Ethanol and xylene for 10 min each and mounted with Roti-Histokitt II. 
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2.4. Apoptosis assay 
 
To analyze apoptosis, testes were fixed with 3.7 % formaldehyde diluted in PBS 
overnight at 4°C, washed with 70 % Ethanol for 24 h and embedded in paraffin. 
Apoptosis analysis on 7 µm sections was performed using the TACS 2 TdT-DAB kit 
according to manufacturer’s recommendations (Trevigen Inc.). 
 
 
2.5. FACS analysis 
 
For staining of individual germ cell populations, testis single cell suspensions were 
prepared as previously described (Bastos et al. 2005) with some modifications. 
Briefly, two testes were isolated and incubated in 2 ml digestion buffer for 25 min at 
32 °C with gentle shaking. After spinning for 5 min at 100 x g, the tubules were 
resuspended in 2 ml digestion buffer and incubated for further 25 min. The 
suspension was filtered through a 40 µm nylon mesh to remove clumps. After 
washing once in HBSS, the cell pellet was resuspended in incubation buffer to a final 
concentration of 2 millions per 1 ml, supplemented with 0.5 µg/ml Hoechst No.33342. 
The cells were incubated for 1 h at 32°C in the dark. Cells were pelleted at 100 x g 
for 5 min and resuspended in incubation buffer supplemented with propidium iodid for 
staining of dead cells. Suspensions were sorted on the LSR II (BD Biosciences) with 
UV laser excitation wavelength 355 nm and emission filters Hoechst-Blue 405B and 
Hoechst-Red 430A, and analyzed using FACSDiVa software (BD Biosciences).  
For staining of germ cells with an antibody against human CD4, single cell 
suspension was prepared as described above. Cells were resuspended in incubation 
buffer with anti-hCD4-FITC (1:100) and incubated for 30 min at 32°C. Cells were 
analyzed using the LSR II.  
 
Digestion buffer Hanks Balanced Salt Solution (HBSS), 20 mM Hepes pH 7.2, 1.2 mM 
MgSO4x7H2O, 1.3 mM CaCl2x2H2O, 6.6 mM sodium pyruvate, 0.05 % sodium 
lactate, 0.4 mg/ml Collagenase I, DNase I 
Incubation buffer Digestion buffer, 1 % glutamine, 1 % fetal calf serum 
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2.6. Extraction of proteins from testis 
 
For nuclear extracts, mice were dissected and both testes were minced using a 
dounce homogenizer (loose) in 1 ml PBS. After centrifugation at 200 x g, 4°C for 5 
min, cells were resuspended in 1ml cold buffer B. Cells were dounced with a tight 
pestel 20-30 times. To pellet nuclei cells were centrifuged for 3 min at 5900 x g. The 
supernatant correspond to the cytoplasmic fraction. Nuclei were resuspended in 250 
µl buffer C. 1/10 Vol of ammonium sulfate pH 7.4 was added, mixed immediately and 
incubated on ice for 30 min with occasional shaking. Centrifugation in an 
ultracentrifuge at 40000 x g, 4°C for 30 min followed. The supernatant correspond to 
the nuclear fraction. Fractions can be stored at -80°C after supplement of 10 % 
glycerol and 100 mM NaCl.  
For total cell lysates (RIPA extract), two testes were dounced (tight pestel) in 500 µl 
complete RIPA buffer. After incubation on ice for 10 min, lysates were centrifuged for 
20 min at highest speed, 4 °C. The proteins resided in the supernatant and after 
addition of 100 mM NaCl and 10 % glycerol, the extracts can be stored at -20°C. 
Protein concentration was measured with Roti®-Quant according to manufacturers 
recommendations using a micro plate spectrophotometer.  
 
 
Buffer B  5 mM KCl, 40 mM Tris pH 7.5, 2 mM EDTA, 0.5 mM vanadate, 2 mM PMSF, 10 mM  
 Na2S2O5, 50 µg/ml TLCK, 2 mM DTT, Complete (Roche) 
Buffer C  5 mM KCl, 0.5 mM EDTA, 15 mM Tris pH 7.5, 2 mM PMSF, 10 mM Na2S2O5,  
  50 µg/ml TLCK, 1 mM DTT, Complete (Roche) 
RIPA buffer  50 mM Tris pH 8.0, 150 mM NaCl, 0.5 % deoxycholate, 1 % NP-40, 0.1 % SDS,  
  50 mM NaF, 0.2 % PMSF, TLCK, Na2S2O5 
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2.7.  Immunoblotting of protein extracts 
 
Protein pattern were analyzed using SDS-PAGE. 40 µg of protein extract were 
separated on a 7.5 % SDS gel. Gels were either stained with Coomassie Brilliant 
Blue or blotted to a HybondTM-C membrane using the Mini Trans-Blot® 
Electrophoretic Transfer cell (Bio-Rad) for 2 h with 100 Volt. After staining with 
Ponceau red, the membrane was blocked for 1 h with blocking buffer. Three wash 
steps with PBS-T followed and the first antibody was incubated overnight at 4°C. 
Next day the membrane was washed and incubated with the secondary antibody 
diluted in PBS-T for 1 h at RT. After washing with PBS-T, the membrane was 
covered with detection reagent for 1 min and luminescence was detected using the 
KODAK Image Station 2000MM.  
 
PBS-T    1x PBS, 0.1 % Tween-20 
Blocking buffer   PBS-T, 5 % milk powder 
Ponceau red   2 % Ponceau S, 30 % Trichloroacetic acid, 30 % Sulfosalicylic acid in H2O 
 
 
For immunoblot analysis following antibodies were used:  
 
Antibodies for Immunoblot Provider Dilution 
Rabbit polyclonal α -MVH/DDX4 Abcam 1 µg/ml 
Rabbit polyclonal α -PIWIL2 Abcam 1 µg/ml 
Rabbit polyclonal α -RNF17 J. Wang, UPenn 1:1000 
Rabbit polyclonal α -HIWI Abcam 0.5 µg/ml 
Rabbit polyclonal α -MAEL Abcam 1 µg/ml 
Rabbit polyclonal α -TDRDN PA #27459  5 µg/ml 
Rabbit polyclonal α -TDRDC AG #27507  8 µg/ml 
Rabbit polyclonal α -SP1 Bethyl Lab. 1 µg/ml 
α -rabbit-HRP Jackson Lab 1:10000 
α -mouse-HRP Jackson Lab 1:10000 
Table 2.2: Antibodies and the respective concentrations used for immunoblotting. 
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2.8.  Immunofluorescence of testis sections  
 
Native testes were frozen in Tissue Tek O.C.T.TM compound and cut in 7 µm sections 
using the Leica CM1900 Cryostat. After fixation in ice-cold methanol/acetone for 10 
min, slides were washed in PBS 3 x 5 min. Slides were blocked in prewarmed PBTG 
at 37°C for 5 min. Antibodies were diluted in PBTG, covered with Parafilm and 
incubated overnight at 4°C in a humid chamber. For staining with the LINE-1 
antibody, slides were fixed with 3.7 % PFA for 20 min on ice. After incubation in 
PBS/Triton for 4 min, slides were washed 3 x 10 min with PBS. The antibody was 
diluted in PBS with 2 % goat serum and incubation was carried out overnight at 4 °C. 
Slides were washed 4 x 5 min with PBTG at 37°C and incubated with the secondary 
antibody diluted in PBTG for 1 h at 37°C in a humid chamber. After washing 4 x 3 
min with PBTG, slides were mounted with Fluoromount and covered with a coverslip. 
Fluoromount was supplemented with DAPI to visualize nuclei. Stainings were 
analyzed using the fluorescence microscope Axiophot (Zeiss) with the corresponding 
AxioVision 4.6 software. 
 
Methanol/Acetone  4 Vol Methanol, 1 Vol Acetone 
3.7 % PFA  3.7 % Paraformaldehyde in PBS 
PBS/Triton  0.1 % Triton in PBS 
PBTG    0.1% BSA, 0.5% Fish Gelatine, 0.05% Tween 20 in PBS 
 
For immunofluorescence (IF) analyses following antibodies were used: 
Antibodies for Immunofluorescence Provider Dilution Fixative 
Rabbit polyclonal α - MVH Abcam 1 µg/ml Methanol/Acetone 
Rabbit polyclonal α - HIWI (MIWI) Abcam 2 µg/ml Methanol/Acetone 
Rabbit polyclonal α - MAEL Abcam 2 µg/ml Methanol/Acetone  
Rabbit polyclonal α - TDRDN (PA)  0.4 mg/ml Methanol/Acetone 
Rabbit polyclonal α - TDRDC #27477 (AG)   4.2 µg/ml Methanol/Acetone  
Rabbit polyclonal α - L1 Orf1p S. Martin (Berkeley Univ.) 1:500 3.7 % PFA 
Mouse IgG1 hybridoma α - SYCP3 C. Heyting (Wageningen Univ.) 1:1 PBS-T Methanol/Acetone  
Secondary antibodies    
Goat α - rabbit IgG-Biotin Dianova (Jackson Lab) 1:500  
Donkey α - mouse IgG - Biotin Dianova (Jackson Lab) 1:500  
Goat α - rabbit IgG - Cy3 Dianova (Jackson Lab) 1:500  
ExtrAvidin® - Cy3 Sigma 1:1000  
ExtrAvidin® - FITC Sigma 1:1000  
Table 2.3: Antibodies and the respective dilutions and fixation methods used for IF. 
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2.9.  DNA isolation from testes and tails 
 
Testes were isolated from mice and a single cell suspension by dounce 
homogenization was prepared. Cells were harvested by centrifugation and 
resuspended in lysis buffer (106 cells/50 µl) and incubated overnight at 55°C with 
intense shaking. For DNA isolation from mice tails, tails were incubated in 500 µl lysis 
buffer at 55 °C overnight. After centrifugation for 2 min at 16000 x g the supernatant 
was transferred to a fresh tube. 
For both protocols, an equal volume of Phenol-Chloroform (1:1) was added, mixed 
and centrifuged for 5 min at highest speed. The upper aqueous phase was 
transferred to a new tube. An equal volume of Chloroform was added, the two 
phases were mixed and after centrifugation, the supernatant was transferred to a 
fresh tube. DNA was precipitated with 2 vol of 96 % ethanol. The mixture was 
centrifuged at 16000 x g for 5 min and the pellet was washed with 70 % ethanol. The 
DNA was dried and resuspended in an appropriate volume of TE buffer. DNA 
concentration was measured using a Nanodrop. 
 
Lysis buffer testis  10 mM Tris-HCl pH 8.0, 10 mM EDTA, 100 mM NaCl, 40 mM DTT, 2 % SDS, 
   20 µg/ml Proteinase K 
Lysis buffer tail   50 mM Tris-HCl pH7.5, 50 mM EDTA, 0.5 % SDS, 0.2 M NaCl,  
   0.2 mg/ml Proteinase K 
TE buffer  10 mM Tris-HCl pH 7.5, 0.1 mM EDTA 
 
 
2.10.  Genotyping 
 
For genotyping the mice, tail DNA was isolated and analyzed by polymerase chain 
reaction (PCR) using the Taq DNA Polymerase from Invitrogen. For the wild-type 
locus a band of 685 bp and for the knockout locus a band of 292 bp is expected. For 
primer sequences refer to table 2.4. Following reagents were mixed and PCR 
settings were applied (Eppendorf Mastercycler® ep): 
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Reagents     25 µl total  PCR settings       
DNA        0.5 µl  
10 x buffer       2.5 µl 
50 mM MgCl2     1.25 µl   94°C    3 min 
10 pmol Primer forward  (Tdrd6ShArmgeno_for)   0.5 µl   94°C 30 sec   
10 pmol Primer reverse I (hCD4_rev)  0.25 µl   63°C      30 sec    x 35 cycles 
10 pmol Primer reverse II (Tdrd6genoWT_rev) 0.25 µl   72°C   1 min   
dNTPS (10 mM of dATP, dCTP, dGTP, dTTP)   0.5 µl   72°C 10 min 
DMSO      1.25 µl 
Taq polymerase       0.1 µl 
water       17.9 µl 
 
 
2.11.  Southern Blotting 
2.11.1. Probe labeling  
 
The Southern Blot (Southern 1975) was an additional method to analyze the 
genotype of the mice. For this, the targeting vector pTV-Uni-Tdrd6 (Figure 2.1) was 
digested with EcoRI and KpnI. The resulting 1.4 kb fragment was gel-extracted using 
the gel extraction kit from Qiagen. 50 ng of the DNA fragment was used for labeling 
with α-32P-dCTP (PerkinElmer) by using the Prime-It labeling kit from Stratagene, 
following the manufacturer’s recommendations. For the Line-1 Southern Blot the 
probe was designed like described previously (Carmell et al. 2007) using primers 
listed in table 2.4. 
  
2.11.2. Hybridization  
 
Southern Blot was done as described previously (Sambrook and Russell 2001). 15 
µg (Genotyping Southern Blot) or 5 µg (Line-1 Southern Blot) of testis or tail DNA 
was digested with the appropriate restriction enzymes (Genotyping: BglII, Line-1: 
MspI, HpaII) overnight. DNA was run on a 0.8 % agarose gel prepared in 1 x TBE. 
After taking a picture using UV light, the gel was incubated in denaturing solution for 
30 min on a shaker at RT. Other incubation steps in neutralization solution for 2 x 15 
min followed. The gel was placed upside-down on a piece of Whatman 3 MM paper, 
both were put on a tray within a bigger dish, making a bridge in 20 x SSC. The 
membrane was placed on the gel and was covered with 3 layers of pre-wetted 
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Whatman 3 MM paper and a stack of paper tissues. The stack was covered with a 
glass plate and a weight of approximately 1 kg was placed on top. The transfer was 
done overnight. The next day the DNA was fixed on the membrane by cross-linking 
with UV light. After rinsing the membrane in 2 x SSC, it was pre-hybridized for a few 
hours in a rotating oven at 60°C with PerfectHyb® buffer. The radioactive labeled 
probe was diluted in 10 ml fresh PerfectHyb® buffer and hybridized to the membrane 
overnight at 60°C in a rotating oven. The next day the probe was collected and was 
stored at -20°C in a protected box. The membrane was rinsed in wash buffer I for 1 
min, and 2 times incubated with wash buffer II for 30 min at 60°C. After washing, the 
membrane was exposed for several hours up to overnight to a Phosphor screen. The 
Southern Blot was analyzed using a PhosphorImager (Molecular Dynamics) and the 
ImageQuant 5.1 software. 
 
10 x TBE    0.89 M Tris, 0.89 M Boric acid, 2 mM EDTA, pH 8.9 
Denaturing solution   500 mM NaOH, 1.5 M NaCl 
Neutralization solution   500 mM Tris-HCl pH7.2, 1.5 M NaCl, 1 mM EDTA 
20 x SSC   3 M NaCl, 0.3 M C6H5Na3O7 x 2 H2O (Sodium citrate) 
Wash buffer I    2 x SSC, 0.1 % SDS 
Wash buffer II    100 mM Na2HPO4, 0.1 % SDS 
 
 
2.12.  Electron microscopy 
 
Seminiferous tubules were dissected from mouse testis, fixed in 0.1 M phosphate 
buffer (pH 7.4) containing 2 % glutaraldehyde for 1.5 h and post-fixed in 1 % osmium 
tetroxide in water for 1 h. Samples were dehydrated through a graded series of 
ethanol and thin-layer embedded in Epon/Araldite as described (Muller-Reichert et al. 
2003). Ultrathin sections (70 nm) were stained using 2 % uranyl acetate in 70 % 
methanol followed by lead citrate and imaged in a TECNAI 12 transmission electron 
microscope (FEI) operated at 100 kV. 
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2.13.  Gene expression analyses 
 
2.13.1. Whole mouse genome analyses 
 
To analyze gene expression in Tdrd6-deficient mice, total testis RNA of 18-days-old 
mice was purified using TRIzol® reagent according to the manufacturer’s 
recommendations. The integrity of RNA was analyzed by running on the Bioanalyzer 
2100 (Bio-Rad). RNA was labeled using the One-Color Microarray-Based Gene 
Expression Analysis System from Agilent Technologies (Agilent 2007) according to 
manufacturer’s recommendation. Briefly, cDNA of total testis RNA was synthesized 
and labeled with Cyanine 3-CTP and hybridized to 4x44K whole mouse genome 
microarrays (Agilent). Data were analyzed using the GeneSpring 7.3 software 
(Agilent).  
 
 
2.13.2. Quantitative real time PCR 
 
RNA from testes was purified using TRIzol® reagent according to the manufacturer’s 
recommendations. DNA was digested with DNase I, and reverse transcription was 
carried out using the Superscript RT from Invitrogen. Primers used for analyzing 
gene expression are listed in table 2.4. For quantitative real time PCR the SYBR 
green kit from Qiagen was used according to the manufacturer’s recommendations. 
Samples were analyzed using the Corbett RG-3000 system. 
 
 
2.13.3. MiRNA expression analyses 
 
Total testis RNA was isolated from 18-days-old mice using TRIzol® reagent according 
to the manufacturer’s recommendations. MiRNA expression analyses were carried 
out using the miRXploreTM Standard Service (Miltenyi Biotech GmbH). Data were 
normalized by applying the 50th percentile of background value and by performing the 
Lowess normalization. Additionally, data from mature miRNA analyses were 
validated by quantitative real time-PCR according to (Sharbati-Tehrani et al. 2008) 
using the Corbett RG-3000 system. Briefly, reverse transcription on total testis RNA 
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was performed with an oligonucleotide (RT6-miR-x) that hybridizes to the 3’ end of 
the respective miRNA. For subsequent qRT-PCR (QuantiTect SYBR Green PCR Kit, 
Qiagen) another miRNA-specific primer as well as two universal primers were used 
(Table 2.4). Precursors of miRNAs were analyzed according to (Davis et al. 2008). 
The results of qRT-PCR assays presented are an average of three independent RNA 
preparations and each sample was analyzed in triplicates. Statistical analyses were 
performed using One-way ANOVA followed by Bonferroni post tests (GraphPad 
Prism software). 
 
 
2.14.  Bioinformatic analyses 
 
Following bioinfomatic databases were used:  
 
- Ensemble (www.ensembl.org/index.html) and MGI (www.informatics.jax.org/): 
Information about gene sequences and localization 
 
- miR-Base database (http://microrna.sanger.ac.uk/): miRNA accession 
numbers, as well as cluster and promoter analyses. 
 
- TargetScanS (www.targetscan.org) and TarMir (www.tarmir.rgcb.res.in/): 
miRNA/mRNA target prediction 
 
- miRDB (http://mirdb.org/miRDB/): prediction of mRNAs and their hypothetical 
miRNAs (Wang 2008) 
 
- MAPPER (http://snpper.chip.org/mapper/mapper-main): analyses of putative 
transcription factor binding sites in promoter regions of mRNAs  
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ShArm forward 5’- GAATTCTTCAAGGATAAGCTCAACGTGGAGAA 
ShArm Reverse 5’- CGCCAACCGAGAGCT 
LongArm forward 5’- GAAAATTTAAATACAAAGAAGTTAGCTCAGATTTG 
LongArm reverse 5’- CAGTTTAAACGCTAACATGCTAACACTA  
hCD4 reverse 5’- GGGAAGCTGTACAGGTCAGTTCCA 
Tdrd6ShArmgeno forward 5’- GGCTGCTACCAGTCGCGAGTC 
Tdrd6genoWT reverse 5’- ATGGAGGAGCAACACATCCAGGAC 
Tdrd6 RT-fwd 5’- GAAGGAAGGAAGTGCGGGAGC 
Tdrd6 RT-rev 5’- CACCTCCACACGCCTCCTCC 
Cterm-fwd BglII 5’- GCCAGAtctGGAAGGAAGTGCG 
C-term-revXhoI 5’- ATGCTCGAGTCATATGTTCAGC 
Nterm-fwdBglII 5’-TCGAGATCTACTCCGGGGCTGC 
Nterm-revXhoI 5’-CCTCGAGGGGCAGGTGGAAGA 
Actin-F (qRT-PCR) 5’- AGGCATTGCTGACAGGATGCAG 
Actin-R (qRT-PCR) 5’- AGCACTTGCGGTGCACGATG 
GAPDH-F (qRT-PCR) 5’- GAGAAACCTGCCAAGTATGATG 
GAPDH-R (qRT-PCR) 5’- GGAGTTGCTGTTGAAGTCGC 
MP-F (miR-qRT-PCR) 5’- TGTCAGGCAACCGTATTCACC 
MP-R (miR-qRT-PCR) 5’- CGTCAGATGTCCGAGTAGAGG 
5S rRNA-F (miR-qRT-PCR) 5’- GCCCGATCTCGTCTGATCT 
5S rRNA-R (miR-qRT-PCR) 5’- AGCCTACAGCACCCGGTATT 
RT-miR-29b-1(miR-qRT-PCR) 5’- TGTCAGGCAACCGTATTCACCGTGAGTGGTAACACT 
RT-miR-29c(miR-qRT-PCR) 5’- TGTCAGGCAACCGTATTCACCGTGAGTGGTTAACCG 
RT-miR-34a(miR-qRT-PCR) 5’- TGTCAGGCAACCGTATTCACCGTGAGTGGTACAACC 
RT-miR-34c(miR-qRT-PCR) 5’- TGTCAGGCAACCGTATTCACCGTGAGTGGTCCTGGC 
RT-miR-322(miR-qRT-PCR) 5’- TGTCAGGCAACCGTATTCACCGTGAGTGGTTCCAAA 
RT-miR-342(miR-qRT-PCR) 5’- TGTCAGGCAACCGTATTCACCGTGAGTGGTCCTGGC 
Short-miR-29b1R(miR-qRT-PCR) 5’- CGTCAGATGTCCGAGTAGAGGGGGAACGGCGTAGCACCATTTGAAATCAG 
Short-miR-29c-R(miR-qRT-PCR) 5’- CGTCAGATGTCCGAGTAGAGGGGGAACGGCGTAGCACCATTTGAAATCGG 
Short-miR-34a-R(miR-qRT-PCR) 5’- CGTCAGATGTCCGAGTAGAGGGGGAACGGCGTGGCAGTGTCTTAGCTCC 
Short-miR-34c-R(miR-qRT-PCR) 5’- CGTCAGATGTCCGAGTAGAGGGGGAACGGCGAATCACTAACCACACAGC 
Short-miR-322-R(miR-qRT-PCR) 5’- CGTCAGATGTCCGAGTAGAGGGGGAACGGCGCAGCAGCAATTCATGTTT 
Short-miR-342-R(miR-qRT-PCR) 5’- CGTCAGATGTCCGAGTAGAGGGGGAACGGCGAGGGGTGCTATCTGTGAT 
Pri-miR-29b1-F(miR-qRT-PCR) 5’- TGTAAGCCTCGTGCTCACTG 
Pri-miR-29b1-R(miR-qRT-PCR) 5’- GAAGGTGAAGTCCGTGCAAT 
Pre-miR-29b1-F(miR-qRT-PCR) 5’- AGGAAGCTGGTTTCATCTGG 
Pre-miR-29b1-R(miR-qRT-PCR) 5’- AGAACACTGATTTCAAATG 
Pri-miR-29c-F(miR-qRT-PCR) 5’- AGCAAGGAAGGGGTAAGAGC 
Pri-miR-29c-R(miR-qRT-PCR) 5’- ACCGACTGGTGGTGTTCTTC 
Pre-miR-29c-F(miR-qRT-PCR) 5’- ATCTCTTACACAGGCTGACC 
Pre-miR-29c-R(miR-qRT-PCR) 5’- TCCCCCTACATCATAACCGA 
Pri-miR-34a-F(miR-qRT-PCR) 5’- TCCTGACTCAGCCTCCTTGT 
Pri-miR-34a-R(miR-qRT-PCR) 5’- TGACACACTCCTCCAGCACT 
Pre-miR-34a-F(miR-qRT-PCR) 5’- CCAGCTGTGAGTAATTCTTT 
Pre-miR-34a-R(miR-qRT-PCR) 5’- ACAATGTGCAGCACTTCTAG 
L15UTR-F 5’- GGCGAAAGGCAAACGTAAGA 
L15UTR-R 5’- GGAGTGCTGCGTTCTGATGA  
Table 2.4: Primer sequences used for these thesis. 
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3.  Results 
 
3.1.  Generation of TDRD6 C- and N-terminal antibodies 
 
TDRD6 is expressed exclusively in testis cells during spermatogenesis. In the 
transition from diploid to haploid cells, the protein is cleaved by an unknown process. 
We speculate, that Caspase I cleaves TDRD6 at the C-terminal end, since there is a 
predicted cleavage site in a respective distance from this end. To verify if the 
cleavage really occur at the C-terminal end, we generated two different antibodies 
specific for each terminus of the protein. 
The respective peptides for the TDRD6 N-terminal and C-terminal antibodies were 
overexpressed in bacteria and purified on glutathione agarose. Figure 3.1 shows the 
purified peptides after separation with SDS-polyacrylamide gel electrophoresis 
stained with Coomassie Brilliant Blue. The expected size of the peptides is 40 kDa.  
 
 
 
Figure 3.1: Purified peptides of TDRD6-Cterm (A) and TDRD6-Nterm (B). 
Peptides are separated with SDS-PAGE and stained with Coomassie Blue. 
 
 
After injection of the peptides into rabbits, mixed with Freund’s Adjuvants as an 
immunopotentiator (see table 2.1 for details), the obtained blood sera were purified 
using Protein A-agarose. Figure 3.2 shows the first three fractions of antibodies 
purified with Protein A-agarose beads for each immunized rabbit. The heavy (50 kDa) 
and light chains (25 kDa) of the antibodies are visible. These purified antibodies are a 
mixture of all existing antibodies in the rabbit, since Protein A-agarose is suitable of 
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binding all IgG molecules. Table 3.1 gives information of the total amount of 
antibodies, which were obtained from 25-30 ml serum of each rabbit purified with 
Protein A-agarose.   
 
Figure 3.2: With Protein A-agarose purified antibodies from all four rabbits. Antibodies are 
separated with SDS-PAGE and stained with Coomassie Blue; heavy and light chains are visible. 
 
 
 
 
 
 
 
 
Table 3.1: Obtained amount of antibodies from 25-30 ml serum of each rabbit. 
 
 
To purify TDRD6 specific antibodies, the respective TDRD6-Cterm peptide was 
coupled to Cyanogen bromide-activated-Sepharose. For TDRD6-Nterm peptides the 
antibody purification using this method was not successful. Figure 3.3 shows the five 
first fractions of the TDRD6-Cterm antibody purification using serum of rabbit #27507. 
Heavy chains of the antibodies are apparent, the light chains are very faint; the total 
amount of purified antibody from 18 ml serum of the first three bleedings was 0,19 
mg.   
Rabbit numeration Peptide Amount of antibody 
#27477 TDRD6-Cterm No. 1 1,3 mg 
#27507 TDRD6-Cterm No. 2 1,8 mg 
#27459 TDRD6-Nterm No. 1 2,2 mg 
#27515 TDRD6-Nterm No. 2 2,1 mg 
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Figure 3.3: Antigen-column purified antibodies of TDRD6-Cterm #27507 
serum. Antibodies are separated with SDS-PAGE and stained with 
Coomassie Blue; heavy and light chains of antibodies are visible. 
 
 
The achieved antibodies were tested by Immunoblotting using total testis protein 
extract. Protein extract from kidney was used as a negative control. Figure 3.4 (A) 
shows the result of probing the membrane with α-TDRD6-Cterm (#27507) and α-
TDRD6-Nterm (#27459), purified by Protein A-agarose. The blot probed with α-Nterm 
antibody shows the two different TDRD6 isoforms at 250 and 230 kDa. The 230 kDa 
isoform gives a more prominent band, since in total testis extract there are much 
more cells expressing the shorter TDRD6 protein. As expected, the blot probed with 
TDRD6-Cterm antibody shows only the 250 kDa isoform, which confirmed our 
hypothesis that the cleavage occurs at the C-terminal end of TDRD6.  
Figure 3.4 (B) shows frozen testis sections stained with either TDRD6-Nterm or 
TDRD6-Cterm antibodies. As expected, the TDRD6-Nterm antibody shows a 
prominent staining of the chromatoid body in round spermatids, as a single red dot. 
In the displayed figure for TDRD6-Nterm, the respective tubules are not in the stage 
to show a cytoplasmic staining of primary spermatocytes, which are stained with the 
synaptonemal complex protein 3 (SYCP3). The staining with the TDRD6-Cterm 
antibody shows no signal of the 230 kDa TDRD6 isoform, which is present in round 
spermatids. Therefore, in these images the primary spermatocytes show a diffuse 
cytoplasmic staining, which correspond to the 250 kDa TDRD6 isoform. Again, our 
hypothesis about the cleavage of TDRD6 at the C-terminal end is approved, since 
the TDRD6-Cterm antibody just recognize the 250 kDa isoform. 
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Figure 3.4: Analyses of two TDRD6-specific antibodies. Immunoblot (A) of testis and kidney total 
cell extract of Tdrd6+/+ mice with two different TDRD6 antibodies. Incubation with α-TDRD6-Nterm 
antibody shows the two different isoforms of TDRD6, whereas incubation with α-TDRD6-Cterm shows 
the 250 kDa isoform. Immunofluorescence (B) of Tdrd6+/+ testes sections with α-TDRD6-Nterm or α− 
Cterm antibody, counterstained with synaptonemal complex protein 3 (SYCP3) with 20-fold and 40-
fold magnification. With α-TDRD6-Nterm antibody spermatocytes and spermatids show a signal for 
TDRD6, whereas with TDRD6-Cterm antibody only spermatocytes show a diffuse cytoplasmic TDRD6 
signal.  
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3.2.  Generation of a Tdrd6 knockout mouse model 
 
The Tdrd6 knockout mouse model was established to analyze the role of TDRD6 
during spermatogenesis. Figure 3.5 shows in detail the targeted disruption of the 
Tdrd6 locus. Exon 1, representing 95 % of the Tdrd6 gene, was replaced with the 
hCD4 gene, lacking the cytoplasmic tail responsible for intracellular signaling.  
 
 
 
Figure 3.5: Schematic representation of the wild-type allele, the targeting vector and the 
mutated Tdrd6 allele. B, BglII cleavage site for later Southern Blot analyses. 
 
 
After electroporation of the targeting vector into embryonic stem cells and selection 
for clones carrying the vector, one positive clone among 300 was identified bearing 
one targeted allele. This clone was injected into a BL6 blastocyst and the resulting 
offspring transmitted the mutation into the germ line. As shown in figure 3.6 the Tdrd6 
mRNA and protein are present in Tdrd6+/-, but absent from Tdrd6-/- testis.   
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Figure 3.6: Analyses of Tdrd6+/+, Tdrd6+/- and Tdrd6-/- mice. (A) PCR for the Tdrd6 locus. For the 
wild-type locus a band of 685 bp and for the knockout a band of 292 bp is expected. (B) Southern 
Blotting using a probe for Tdrd6. For the wild-type locus a band of 6.6 kb and for the knockout a band 
of 4.2 kb is expected. (C) RT-PCR shows a 349 bp band for Tdrd6+/+ and Tdrd6+/-, but not for Tdrd6-/- 
mice. (D) Immunoblotting using an α-TDRD6-Nterm antibody (#27459). The two isoforms of TDRD6 
are visible, with the more prominent 230 kDa isoform. 
 
 
 
 
3.3.  Characterization of the Tdrd6-/- mouse phenotype 
3.3.1. Mouse colony 
 
Tdrd6-/- mice are viable and show apparently normal development except in male 
gonads. Interbreeding of Tdrd6+/- mice produces offspring of normal litter size and 
yields the Mendalian ratios of Tdrd6+/+, Tdrd6+/- and Tdrd6-/- mice. Whereas the 
female Tdrd6-/- mice are fertile, the males are sterile. Tdrd6-/- testes of 20-day-old 
males are the same size as those from wild-type littermates, which suggests normal 
development of spermatogonia, primary, and secondary spermatocytes. However, at 
six weeks of age, the Tdrd6-/- males present up to 25 % smaller testes than those of 
control littermates.  
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3.3.2. Expression of hCD4 under the Tdrd6 promoter 
 
Due to the insertion of the truncated hCD4 gene, lacking the cytoplasmic tail 
responsible for intracellular signaling, into the genomic locus of the Tdrd6 gene, the 
expression of hCD4 is driven by the endogenous Tdrd6 promoter. Therefore, Tdrd6+/- 
derivates of this strain may serve as a very useful tool to identify, sort, and 
investigate separate postpachytene germ cell populations. Fluorescence activated 
cell sorting (FACS) analysis (figure 3.7) of testis, kidney and human peripheral blood 
monocytes (hPBMC) shows, that testis cells express the hCD4 on their surface. 
Kidney cells were used as a negative control and the hPBMC, which normally 
express hCD4, as a positive control.  
 
 
 
Figure 3.7: FACS analysis of α-hCD4 stained total testis cell suspension from Tdrd6+/- mice. 
Kidney cell suspension and human peripheral blood monocytes (hPBMC) were used as controls. In 
blue, hCD4 positive stained cells in testis, as well as in the positive control. In red, hCD4 negative 
cells. 
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3.3.3. Histology of testes sections  
 
To get first information about the assembly of the Tdrd6-/- testes, histological 
analyses were done by staining paraffin-embedded testes sections with periodic 
acid-Schiff (PAS) and Hematoxylin. Periodic acid-Schiff stains all carbohydrates in 
pink and Hematoxylin stains basophilic structures like nuclei in blue. In figure 3.8 
Tdrd6+/- and Tdrd6-/- testis sections with tubules in various stages are shown. Mature 
spermatozoa are completely absent from the lumen of the tubules and from the 
epididymes of Tdrd6-/- mice. Elongated spermatids are almost completely missing, 
which leads to sterility of the Tdrd6-/- mice. Some giant cells are visible in the tubules 
of Tdrd6-/- mice, which are most probably apoptotic cells. The absence of mature 
sperm was additionally observed by electron microscopy of testis tubules (figure 3.9). 
 
 
 
Figure 3.8: Testes from adult Tdrd6+/- (A,B) and Tdrd6-/- (C,D) littermates were stained with 
periodic acid-Schiff (PAS) reagent and hematoxylin. Seminiferous tubule stages are indicated by 
roman numerals in the center. Testes sections of Tdrd6-/- mice lack elongated spermatids and mature 
sperm. Sg, spermatogonia; ps, primary spermatocytes; ss, secondary spermatocytes; rs, round 
spermatids; es, elongated spermatids; s-zoa, spermatozoa. 
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Figure 3.9: Electron microscopy of seminiferous tubules. In stage I seminiferous tubules of 
Tdrd6+/- (A) and Tdrd6-/- mice (B) elongated spermatids are apparent. Due to a block in 
spermiogenesis, stage V seminiferous tubules of Tdrd6-/- mice (D) lack elongated spermatids, while 
they are present in Tdrd6+/- mice (C) (bar 10 µm). 
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3.3.4. Germ cell populations in Tdrd6-/- mice 
 
The absence of elongated spermatids in adult mice was confirmed by Fluorescence 
activated cell sorting (FACS) using the LSR II. Testis cells of 10-week-old mice were 
isolated by collagenase treatment, stained with Hoechst dye and analyzed based on 
their DNA content. Figure 3.10 shows the FACS plot of the different germ cell 
populations of Tdrd6+/- and Tdrd6-/- mice. Spermatogonia and somatic cells are not 
highlighted. Spermatocytes I are the largest cells with a DNA content of 4 n and 
represent 8.75 % in the Tdrd6+/- and 12 % in the Tdrd6-/- mouse. After meiosis 
division I they become spermatocytes II with a DNA content of 2 n (8.79 % Tdrd6+/-, 
14.4 % Tdrd6-/-). Round spermatids (RS) are small cells with a DNA content of 1 n 
and, in these preparations, are the most abundant cell population with 40.1 % in the 
Tdrd6+/- and 44 % in Tdrd6-/- mice. The population of elongated spermatids (ES), 
present with 11.6 % in the Tdrd6+/- mouse, is remarkably reduced to 1.38 % in the 
Tdrd6-/- mouse. This confirmed our observations from the electron microscopy that 
most of the elongated spermatids are missing in Tdrd6-/- testis. 
 
 
 
Figure 3.10: Comparison of the distribution of germ cell populations in 10-weeks-old 
heterozygous (Tdrd6+/-) and homozygous (Tdrd6-/-) mice. Only very few elongated spermatids are 
found in tubules of Tdrd6-/- mice. 
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3.3.5. Analyses of apoptosis in Tdrd6-/- testes sections 
 
Since an arrest in the spermiogenesis of Tdrd6-/- mice at the stage of round to 
elongated spermatids was observed, we asked for an increase in apoptotic cells. 
TUNEL (Terminal deoxynucleotidyl transferase dUTP nick end labeling) labeling was 
used to determine the timing of abnormal cell death in the first wave of 
spermatogenesis. In apoptotic cells, DNA fragmentation occurs, and by filling the 
resulting nicks with labeled nucleotides and following incubation with horseradish 
peroxidase, these cells develop a brown staining. We analyzed mice of different age, 
from 18 days to 22 days post partum. Figure 3.11 shows testes sections of 19 days 
old Tdrd6+/- and Tdrd6-/- mice counterstained with methyl green, in brown apoptotic 
cells. Until day 18 post partum no difference in the number of abnormal cell death 
was visible (figure 3.11 C). From day 19 post partum on, a 4-fold increase of 
apoptotic cells in Tdrd6-/- testes sections in comparison to Tdrd6+/- sections was 
observed. Statistic analyses revealed a significant increase (day 19 *, P-value 
0.0459, day 20 ***, P-value  <0.0001, day 22 **, P-value 0.0036).  
 
 
 
Figure 3.11: Apoptosis in Tdrd6+/- (A) and Tdrd6-/- (B) testes. Testes from 19-day-old heterozygous 
and homozygous mutant littermates were stained with the TUNEL technique. Figure C shows a 
quantification of apoptosis in the testes of juvenile mice. From day 19 on, Tdrd6-deficient mice show a 
4-fold increase of apoptotic cells. 
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3.3.6. Electron microscopic analysis of the chromatoid body 
 
Since TDRD6 is localized to the chromatoid body in round spermatids we subjected 
this structure closer examination using high-resolution morphological analysis by 
transmission electron microscopy. In figure 3.12 chromatoid bodies of Tdrd6+/- and 
Tdrd6-/- mice using different magnifications are displayed. CBs were observed at 
similar frequencies, and in the same close proximity to the nuclear membrane in 
round spermatids of Tdrd6+/- and Tdrd6-/- mice of the same stage. In Tdrd6-/- 
spermatocytes and round spermatids, subcellular structures such as synaptonemal 
complex and acrosomes do not differ from control mice. The most striking difference 
in round spermatids of Tdrd6-/- mice is the disrupted appearance of the chromatoid 
bodies. Whereas the CBs in Tdrd6+/- littermates consist of dense, amorphous 
material, they appear in Tdrd6-/- mice as diffuse structures. The CBs look disrupted, 
less condensed, and incorrectly assembled, a “ghost”-like structure. Therefore, we 
conclude that TDRD6 is essential for the correct assembly of the CBs in round 
spermatids, and their further differentiation into elongated spermatids.  
 
 
Figure 3.12: Electron microscopy of the chromatoid body. (A) and (C) show the fully condensed 
chromatoid bodies near the nuclear membrane in stage I round spermatids in Tdrd6+/- mice. (B) and 
(D) show the dispersed chromatoid bodies in round spermatids of the same stage in Tdrd6-/- mice. 
Scale bar represents 500 nm. 
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3.3.7. Expression of chromatoid body components 
 
Many other proteins localize to the chromatoid body in round spermatids, e.g. mouse 
vasa homolog (MVH), MIWI and Maelstrom. Since we observed, that in the Tdrd6- 
deficient mouse the CB is dispersed and does not look like in wild-type mice, it was 
obvious to investigate the abundance of other CB components in Tdrd6-/- mice. 
Figure 3.13 shows immunoblot analysis of 40 µg of testis and kidney nuclear protein 
extract from Tdrd6+/+, Tdrd6+/- and Tdrd6-/- mice. Different antibodies for CB 
components (MVH, MIWI, MAEL), as well as control proteins (SP1, TDRD4/RNF17) 
were applied. All investigated CB components MVH, MIWI and MAEL are expressed 
in the same amount in the Tdrd6-/- protein extract as in the control mice (figure 3.13). 
We conclude that TDRD6 has no effect on the expression of these investigated 
proteins. 
 
 
Figure 3.13: Immunoblot of nuclear extracts from testis and kidney from Tdrd6+/+, 
Tdrd6+/- and Tdrd6-/- mice. Extracts were probed with specific antibodies for chromatoid 
body markers TDRD6, PIWIL2 (MILI) HIWI (MIWI), MVH, MAEL, and for control RNF17 
and SP1. No differently expression of CB markers is observed in Tdrd6-/- mice. 
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3.3.8. Localization of chromatoid body components 
 
As shown in figure 3.13, other chromatoid body components like MVH, MIWI and 
Maelstrom are expressed in Tdrd6-deficient mice. Next the localization of these 
proteins was examined. In wild-type mice these proteins localize to the CB in round 
spermatids, which is disrupted in Tdrd6-/- mice. Figure 3.14 shows 
immunofluorescence staining of testis section from Tdrd6+/- and Tdrd6-/- mice using a 
40-fold magnification. The sections are stained with antibodies against MVH, MIWI 
and MAEL (Cy3 in red). Each slide is counterstained with the synaptonemal complex 
protein 3 (SYCP3; FITC in green) to highlight the chromosomes in primary 
spermatocytes. In Tdrd6+/- testis sections a clear “single dot” signal is visible for 
MVH, MIWI and Maelstrom in round spermatids, which indicates the chromatoid 
body. However, in Tdrd6-/- testis sections a diffuse cytoplasmic staining is visible, but 
the prominent dots in round spermatids disappeared. For MIWI the typical 
cytoplasmic staining in primary spermatocytes is not affected. Thus, localization, but 
not expression of CB components, and certainly CB architecture itself depend on 
TDRD6.  
 
 
Figure 3.14: Mislocalization of CB proteins in Tdrd6-/- spermatids. Testis frozen sections from 
Tdrd6+/- and Tdrd6-/- were immunostained with α-MVH, α-MIWI or α-MAEL antibodies (red). For all 
three proteins, the typical pattern of CB staining seen in the control testes is disrupted in Tdrd6-/-. 
SYCP3 (green) was used to visualize synaptonemal complexes on chromosomes, and nuclei were 
stained in DAPI (blue).  
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3.3.9. Transposon expression in Tdrd6-deficient mice 
 
Piwi domain containing proteins MILI and MIWI2, as well as MAEL, are known to 
regulate retrotransposon activation (Aravin et al. 2007; Carmell et al. 2007; Soper et 
al. 2008). In the respective knockout mice, activity of retrotransposons like LINE-1 
(L1) or intracisternal A-particle (IAP) is strongly increased, due to loss of methylation. 
Transposable elements are thought to be maintained in a silent state by DNA 
methylation of CpG islands in the promoter region.  
We investigated the transcription activity of LINE-1 (L-1) by CpG methylation 
diagnostic Southern blotting. For this, testis and tail DNA were digested using either 
MspI or HpaII. These enzymes are isoschizomers, which recognize the same 
sequence (CCGG) but have different methylation sensitivities. Whereas MspI is not 
sensitive for methylated cytosines, HpaII is blocked and cannot cleave a methylated 
CpG site. By digesting with these two enzymes and Southern blotting with a probe 
against the 5’UTR of L-1, one can conclude about the methylation pattern of CpG 
islands in the promoter region and therefore about the activity of this transposon. The 
probe recognizes four bands of 156 bp generated by HpaII/MspI sites in the 5’UTR, 
and a band of 1206 bp that is generated by one cleavage site in the 5’UTR and one 
site in the coding sequence (Carmell et al. 2007). Obviously, there is no difference in 
the methylation pattern of the L-1 5’UTR between Tdrd6-deficient and control mice 
(figure 3.15). As expected, after digestion of testis and tail DNA with MspI, the correct 
bands appeared after hybridization with the L-1 probe. Since in the HpaII digested 
DNA no bands appear, we can conclude, that the 5’UTR of Line-1 is properly 
methylated in both, Tdrd6+/- and Tdrd6-/- mice. 
Additionally, we examined LINE-1 expression in Tdrd6-/- mice by 
immunofluorescence staining of frozen testes sections with an antibody against 
LINE-1 (Branciforte and Martin 1994). Primary spermatocytes of a certain stage show 
a cytoplasmic staining of LINE-1, visible in figure 3.15 (B) with a 10-fold 
magnification. No obvious difference in this staining is visible between Tdrd6+/- and 
Tdrd6-/- mice. So far, we can conclude that there is no significant up-regulation of 
LINE-1 transposon activity in Tdrd6-deficient. 
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Figure 3.15: LINE-1 transposon methylation and expression in Tdrd6-/- mice. In figure (A) testis 
and tail DNA of Tdrd6+/- and Tdrd6-/- mice were analyzed by Southern Blotting after digestion with 
HpaII and MspI, using a radioactive labeled probe against Line-1. No difference in the methylation 
pattern in the promoter region of Line-1 is observed. In (B) testes sections of Tdrd6+/- and Tdrd6-/- were 
stained with an α-LINE-1 antibody (red), nuclei are visualized with DAPI. No difference in LINE-1 
expression is visible. 
 
 
 
3.4.  Gene expression analysis 
3.4.1. MiRNA expression analysis 
 
RNA and RNA-processing enzymes reside in the CBs, including proteins involved in 
the miRNA pathway. The abnormal architecture of the CB in Tdrd6-/- spermatids and 
the mislocalization of MVH, MIWI and MAEL may affect the regulation of miRNAs. 
For this purpose, total testis RNA of three pairs of 18-days-old Tdrd6-/- and Tdrd6+/- 
mice was isolated. MiRNA expression was analyzed using the miRXploreTM Standard 
Service (Miltenyi Biotech GmbH), which are designed to detect only mature miRNAs 
and not miRNA precursor forms. This age was chosen to avoid any side effects due 
to apoptosis, because later (from 19 days of age) an increase in apoptotic cells was 
observed. Table 3.2 shows the result of all differently expressed mature miRNAs. Of 
the ~ 793 miRNAs known or predicted for mice (TarMir database), 54 miRNAs were 
found up-regulated (>1.5-fold), but only five are down-regulated (<0.7-fold). One 
interesting finding was, that one third of all differentially expressed mature miRNAs 
are located in different clusters on chromosome X. The X chromosome is known to 
be rich in miRNAs specific for testis in mice (Mishima et al. 2008). The largest cluster 
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of mis-regulated miRNA genes on Chr X is the so-called miRNA cluster-19 (miRc-19; 
miR-463, -470, -471, -472, -878-5P, -881*, -743b-3P, -883a-5P, -883b-3P). These 
miRNAs are either testis-specific or highly preferentially expressed in testis, 
suggesting that these miRNAs may have a role limited to spermatogenesis (Ro et al. 
2007a).  
 
Mmu-miR GeneID Fold Genomic Locus Mmu-miR - Cluster Features IG/IT 
-29c 39300 4,3 1:196,863,234-196,863,828 -29b-2, -29c  IG 
-30a* 39306 2,7 1:123,279,108-23,279,178   IG 
-128 39210 1,8 1:130,098,938-130,099,007   IT 
-466a-3P 38815 1,9  IT 
-466a-5P 35833 4,1  IT 
-466b-3P 39949 2,3  IT 
-466b-5P 38810 1,7  IT 
-467a 38825 1,6 
 2: 10,388,571-10,438,791  -466a, -466b, -4667a, -669, -297a,   -297c, -466b-1, -466d 
 IT 
-200a 38505 2,5  IT 
-200b 38723 2,5 4:155,428,014-155,429,859 -200a, -200b, -429  IT 
-30e* 39308 3,1 4:120,442,139-120,445,302 -30c-, 30e  IT 
-34a* 39306 1,3 4:149,442,563-149,442,664   IG 
-339-5P 39327 2,1 5:139,845,604-139,845,699   IT 
-29b-1 38569 1,9 6:  31,012,660-31,013,093 -29a, -29b-1 CpG,TSS IT 
-489 38535 2,4 6:    3,671,301-3,672,003 -489, -653  IG 
-148a 35857 1,9 6:  51,219,811-51,219,909  CpG,TSS IG 
-202 38506 2,8 7:147,143,588-147,143,659  TSS IG 
-140 35847 2,4 8:110,075,144-110,075,213   IT 
-191 39255 0,7 9:108,470,650-108,471,192 -191, 425 CpG IG 
-34c* 39350 1,8 9:  50,911,139-50,911,750 -34a, -34c CpG,TSS IG 
-125b 35830 0,7 9:  41,390,009-41,390,085  TSS IT 
-451 39370 1,6 11:  77,886,507-77,886,743 -144, -451  IG 
-497 35866 3,0 11:  70,048,219-70,048,637 -195, -497  IG 
-21 35883 2,3 11:  86,397,569-86,397,660   IT 
-152 35861 2,0 11:  96,711,707-96,711,779  CpG,TSS IT 
-301a 38983 1,6 11:  86,926,506-86,926,591  CpG.TSS IT 
-379 38528 2,0  IG 
-487b 38377 1,8  IG 
-494 39394 2,5 
 12:110,947,270-110,982,005 
   -134, -154, -299, -300, -323, -329, -369, -377,-376a,  
   -376b, -376c, -379, -380, -381, -382, -409, -410, -411 
   -412, -453,-476, -485, -487b, -494, -495, -496, -539,-541, 
   -543, -544,-654, -666, -667, -668, -679, -758  IG 
-203 38328 2,1 12:113,369,091-113,369,166  CpG,TSS IG 
-342-3P 38991 0,6 12:109,896,830-109,896,928   IT 
-7a 38644 2,8 13:  58,494,140-58,494,247   IG 
-15a 35864 1,8 14:  62,250,717-62,250,947 -15a, -16-1  IG 
-17* 38715 1,9 CpG,TSS IG 
-19a 38326 2,1 14:115,442,893-115,443,728 -17, -18a, -19a, -19b-1, -20a, -92a-1 CpG,TSS IG 
-125a 39208 0,6 17:  17,967,152-17,967,843 Let-7e, -99b, -125a TSS IG 
-204 38727 0,7 19:  22,825,095-22,825,162   IT 
-101b 38961 2,8 19:  29,209,769-29,209,865   IT 
-362-3P 38773 2,5  X:    6,814,809-6,825,623 -188, -362, -500, -501, -532  IT 
-18b 38720 1,7 TSS IG 
-20b 38708 2,2 TSS IG 
-106a 38708 1,5 
 X:  50,094,870-50,095,744   -18, -19b, -20b, 92a, -106a, -363 
TSS IG 
-201 38725 2,2  X:  65,241,271-65,241,626 -201, -547  IG 
-322 35904 1,7 CpG,TSS IG 
-351 38995 2,7 CpG,TSS IG 
-503 38849 2,2 
X:  50,401,174-50,407,526  -322, -351, -450a, -450b, -503, -542 
CpG,TSS IG 
-463 38807 2,9  IG 
-470 38833 1,5  IG 
-471 38834 3,3  IG 
-472 38683 3,7  IG 
-878-5P 38687 2,0  IG 
-881* 40027 2,3  IG 
-743b-3P 38681 2,1  IG 
-883a-5P 40153 3,4  IG 
-883b-3P 38698 1,8 
 X:  64,029,932-63,067,200   -463, -470, -471, -472, -473a, -473b, -880, -881,    -883a, -883b, -871, -878, -889 
 IG 
-465a-5P 38533 4,1  IG 
-465b-5P 38810 1,7  X:  64,079,130-64,092,300  -465a, -465b-1, -465b-2, -465c-1, -465c-2  IG 
-361 35910 1,5 X:110,188,433-110,188,502   IT 
-805 39885 2,0 MT:16,115-16,209   IG 
 
Table 3.2: Differentially expressed miRNAs in testes of 18 days old Tdrd6-/- mice. The genomic 
loci and feature sets used to annotate miRNAs are available through the miRBase database. (CpG, 
CpG island; TSS, transcriptional start sites; IG, intergenic; IT, intronic; *, minor miR* sequences). 
Highlighted in grey are affected miRNA cluster. 
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To validate the microarray data we carried out quantitative real time PCR (qRT-PCR) 
for six randomly chosen mature miRNAs, five up-regulated (miR-29b, -29c, -34a, -
34c and -322) and one down-regulated (miR-342) referred to the microarray results. 
These six miRNAs are known to be expressed in testes of mice (Landgraf et al. 
2007). To evaluate whether up-regulation of such miRNAs occur on the level of 
precursors or mature miRNAs, the pri- and pre-miRNAs, along with the mature forms 
of three miRNAs (miR-29b, -29c, -34a), were analyzed using primers for real time 
PCR, which are specific for each form (figure 3.16). A significant increase of all 
investigated precursors was measured. For the mature miRNAs the referred 
tendency of up- or down-regulation was confirmed to be significant. Since we could 
not only prove changes in expression of mature miRNA, but also in expression of the 
precursors in testes of Tdrd6-/- mice, we assume that TDRD6 is important for 
transcriptional regulation of some miRNAs either due to direct influence – but this is 
unlikely, since Tdrd6 is not visible in the nucleus – or more likely due to an indirect 
influence, e.g. a common transcriptional regulation of miRNA genes through 
transcription factors. Promoter analyses of all investigated mis-regulated miRNA 
genes in the Tdrd6-deficient mice, did not reveal any common features, like 
transcription factors, transcriptional start sites or CpG islands. Furthermore, no 
similarities were found between all mis-regulated miRNAs in respect to their 
localization either intergenic or intronic in the genome (miR-Base database).  
 
Figure 3.16: Differentially expressed precursors and mature miRNAs in testes of Tdrd6-/- mice. Analysis 
was performed with total testis RNA from 18 days old Tdrd6+/- and Tdrd6-/- mice. Precursors (Pri- and pre-
miRNAs) as well as mature miRNAs were analyzed. The values for the Tdrd6+/- control were set to 1.0 and the 
respective increase or decrease in Tdrd6-/- mice are represented as mean +/- SEM (standard error mean). (*** P 
value <0.001, ** P value 0.001 to 0.01, * P value 0.01 to 0.05; ns, not significant P value >0.05). 
Results  53   
              
Targets of miRNAs can be achieved due to analysis of sequence homology between 
mature miRNA and mRNA. These are just hypothetical predictions, and false positive 
hits are possible. The analysis was performed using the TargetScanS database, 
which predicts biological targets of miRNAs by searching for the presence of 
conserved sites that match the seed region of each miRNA. For each investigated 
miRNA more than 500 hypothetical target mRNAs are found. Several families of 
miRNAs are aberrantly regulated, including the miR-29, miR-34, and miR-463 
families. The predicted targets of these miRNAs generally include many testis-
specific RNAs, as well as RNA-processing enzymes like DICER (miR-29). The miR-
463 hypothetically targets TDRD6 itself, and the absence of TDRD6 may cause 
accumulation of this miRNA. Another finding was that miR-34a, which is up-regulated 
in the Tdrd6-/- mouse could theoretically target CUE domain containing protein 1 
(Cuedc1; Chr 11), which was found 4-fold down-regulated in our mRNA microarray 
analyses. MiRNAs like the miR-34 family are known to play a role in tumorigenesis, 
by directly binding to the p53 tumour suppressor gene (He et al. 2007). The miR-29 
family members were described to directly target DNA-modifying enzymes like DNA 
methyltransferases 3 a and b (Fabbri et al. 2007), which together can influence 
tumour progression by modifying methylation patterns. 
 
 
3.4.2. Whole mouse genome analysis  
 
The chromatoid body is a structure where mRNAs are stored and processed. In 
Tdrd6-deficient mice a disrupted CB was observed, which cannot recruit specific 
proteins. Since the CB seems to be not fully functional we decided to investigate, if 
an overall change in mRNA expression is detectable. We isolated total testis RNA 
from 18-days-old Tdrd6-/-, Tdrd6+/- and Tdrd6+/+ mice and analyzed gene expression 
with the One-Color Microarray-Based Gene Expression Analysis System (Agilent 
2007). With a threshold of 2-fold up- and down-regulation and a P-value of 0.05, 109 
mRNAs were found differently expressed. Of these mRNAs, 59 encode known 
proteins, 45 encode undetermined cDNAs (Riken consortium library), and 5 cDNAs 
are unknown at all. Of all differently expressed mRNAs, 69 genes are up-regulated 
and 40 genes are down-regulated (table 3.3). The genes are distributed all over the 
genome, but interestingly 36 % of all genes are located to the centromer-proximal 
end of Chromosome 8 (Chr 8) and 11 % are located to the distal end of chromosome 
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1(figure 3.17). Within the 40 genes located on Chr 8, 19 are protein-coding cDNAs, 
but the remaining 21 genes encode unknown cDNAs listed in the Riken consortium 
library (www.brc.riken.go.jp/lab/dna/en/resourceen.html). 
 
 
Accession no. x-fold up 
x-fold  
down Genomic locus Name 
A_51_P257613  2,25   1:   95,721,817 -  95,748,925 D-2-hydroxyglutarate dehydrogenase (D2hgdh) [NM_178882] 
A_52_P546610  2,91   1:   99,717,672 -  99,992,090 Peptidylglycine alpha-amidating monooxygenase (Pam) [NM_013626] 
A_51_P471386 2,23     1: 106,665,396 - 106,892,058 Cadherin 20 (Cdh20) [NM_011800] 
A_52_P516473 2,01     1: 120,524,522 - 120,581,744 Mus musculus adult male kidney cDNA, RikF530007A16 [AK143960] 
A_52_P243992 2,11     1: 122,518,317 - 122,586,980 Mus musculus 10 days embryo whole body cDNA, Rik2610027F03 [AK011565] 
A_51_P222280  2   1: 133,151,179 - 133,176,140 Inhibitor of kappaB kinase epsilon (Ikbke) [NM_019777] 
A_51_P316661 7,19     1: 135,247,087 - 135,256,902 Renin 1 structural (Ren1) [NM_031192] 
A_52_P192265  3,14   1: 135,247,214 - 135,256,900 Renin 2 tandem duplication of Ren1 (Ren2) [NM_031193] 
A_52_P165824 2,05     1: 135,260,411 - 135,276,892 Ethanolamine kinase 2 (Etnk2) [NM_175443] 
A_52_P616544  6,59   1: 137,006,988 - 137,010,716 Protein tyrosine phosphatase receptor type V (Ptprv) [NM_007955] 
A_51_P150653  2,55   1: 137,006,988 - 137,010,716 Protein tyrosine phosphatase receptor type V (Ptprv) [NM_007955] 
A_51_P103541 2,13     1: 137,949,361 - 138,016,399 Dihydropyridine sensitive skeletal muscle calcium channel (Cacna1s) [L06234]   
A_52_P298112 2,35     2:   17,649,013 - 17,653,091 Mus musculus adult male pituitary gland cDNA, Rik5330423N20 [AK077332] 
A_51_P451374  6,56   2:   76,208,069 - 76,221,822 Developmentally regulated RNA binding protein 1 (Drbp1) [NM_153405] 
A_51_P255646 4,88     2:   86,285,196 - 86,286,137 Olfactory receptor 1065 (Olfr1065) [NM_146408] 
A_52_P614777 2,53     3:   59,885,783 - 59,891,481 Succinate receptor 1 (Sucnr1), mRNA [NM_032400] 
A_51_P440682 2,8     4: 122,536,290 - 122,563,300 CAP, adenylate cyclase-associated protein 1 (yeast) (Cap1) [NM_007598] 
A_52_P658320 2,23     5: 108,870,073 - 108,877,910 Major facilitator superfamily domain containing 7 (Mfsd7) [NM_172883] 
A_52_P25774 3,49     6:   27,225,121 - 28,084,545 Glutamate receptor, metabotropic 8 (Grm8) [NM_008174] 
A_52_P374882 2,33     6:   29,010,220 - 29,023,876 Leptin (Lep) [NM_008493] 
A_52_P568977  2,34   6:   88,674,702 - 88,716,702 Mus musculus adult male testis cDNA, Rik1700074K19 [AK006949] 
A_52_P590535 2,3     6:   91,162,758 - 91,222,534 Fibulin 2 (Fbln2) [NM_007992] 
A_51_P305979 2,06     7: 110,759,924 - 110,760,865 Olfactory receptor 620 (Olfr620) [NM_146812] 
A_52_P672232  2,16   8:     3,538,783 - 3,540,361 Mus musculus cDNA clone IMAGE:3987110, partial cds. [BC020092] 
A_51_P145662  3,69   8:     3,716,084 - 3,720,651 C-type lectin domain family 4, member g (Clec4g) [NM_029465] 
A_52_P70381 2,5     8:     4,238,761 - 4,251,423 Mus musculus 10 days neonate skin cDNA, Rik4732455E07 [AK028772]   
A_52_P730698 3,11     8:     4,332,259 - 4,334,807 Mus musculus adult retina cDNA, RikA930012B14 [AK044424] 
A_52_P947377  6,94   8:     8,377,090 - 8,391,691 Mus musculus 7 days neonate cerebellum cDNA, RikA730008F11 [AK042586] 
A_52_P448994 3,98     8:   11,245,002 - 11,245,605 Mus musculus 15 days embryo head cDNA, RikD930007H16 [AK086129] 
A_52_P373251 2,47     8:   12,757,014 - 12,868,728 Mus musculus cDNA, RikM5C1054M05 [AK147497] 
A_51_P361286 8,29     8:   18,846,279 - 18,884,413 1-acylglycerol-3-phosphate O-acyltransferase 5 (Agpat5) [NM_026792] 
A_52_P578763  5,09   8:   22,194,739 - 22,195,667 Defensin, alpha 1 (Defa1) [NM_010031] 
A_52_P307801   3,56   8:   22,235,000 - 22,275,000 Defensin related cryptdin, related sequence 2 (Defcr-rs2), mRNA [NM_007847] 
A_51_P102081   3,37   8:   22,235,000 - 22,275,000 Defensin related cryptdin, related sequence 2 (Defcr-rs2), mRNA [NM_007847] 
A_51_P377158   2,33   8:   22,235,000 - 22,275,000 Defensin related cryptdin, related sequence 10 (Defcr-rs10), mRNA [NM_007845] 
A_52_P476535 3,9     8:   22,331,293 - 22,332,142 Defensin-related cryptdin 23 (Defcr23), mRNA [NM_001012307] 
A_51_P467086  2,11   8:   22,427,122 - 22,427,971 Defensin related cryptdin 3 (Defcr3), mRNA [NM_007850] 
A_52_P398018  4,27   8:   24,351,798 - 24,367,552 Mus musculus activated spleen cDNA, RikF830033L24 [AK089856]  
A_51_P352296  2,17   8:   24,521,990 - 24,560,099 Secreted frizzled-related sequence protein 1 (Sfrp1) [NM_013834] 
A_52_P577673 13,2     8:   27,187,044 - 27,189,849 Mus musculus 13 days embryo lung cDNA, RikD430019N09 [AK084963] 
A_51_P300960  2,2   8:   32,260,787 - 32,272,345 Mus musculus cDNA sequence BC019943 (BC019943) [NM_144927] 
A_51_P410900 3,79     8:   32,297,850 - 32,371,955 Fucosyltransferase 10 (Fut10) [NM_001012517] 
A_52_P369761  2,25   8:   32,931,245 - 33,028,826 Mus musculus 0 day neonate cerebellum cDNA, RikC230011J18 [AK141037] 
A_52_P369769  2,55   8:   32,947,675 - 33,028,826 Mus musculus 0 day neonate cerebellum cDNA, RikC230013P13 [AK048708] 
A_52_P498492 5      8:   34,346,172 - 34,495,969 Werner syndrome homolog (Wrn) [NM_011721] 
A_51_P202101 32,85     8:   34,841,021 - 34,841,344 Mus musculus adult male testis cDNA, Rik1700104B16 [AK018937] 
A_52_P76104 16,18     8:   38,166,850 - 38,167,524 Mus musculus adult male testis, Rik4933404M01 [AV278908] 
A_51_P236185 18,66     8:   40,194,244 - 40,195,861 Mus musculus adult male diencephalon cDNA, Rik9330142E06 [AK034021] 
A_52_P763167  3,32   8:   41,446,342 - 41,449,492 Mus musculus adult male aorta and vein cDNA, RikA530095A18 [AK041257] 
A_52_P609482 3,7     8:   41,633,626 - 41,635,533 Mus musculus 0 day neonate cerebellum cDNA, RikC230079M10 [AK048897] 
A_52_P77764 3,19     8:   41,947,721 - 42,007423 Solute carrier family 7 member 2 (Slc7a2) [NM_007514]  
A_52_P294510 6,68     8:   42,276,791 - 42,300,507 Fibrinogen-like protein 1 (Fgl1) [NM_145594] 
A_51_P120688 2,077     8:   42,462,790 - 42,466,106 Mus musculus 15 days embryo head cDNA, RikD930046J11 [AK086706] 
A_51_P267544  2,69   8:   42,482,813 - 42,502,428 FSHD region gene 1 (Frg1) [NM_013522] 
A_52_P629849  48,38   8:   44,380,422 - 44,392,334 Zinc finger protein 42 (Zfp42) [NM_009556] 
A_52_P117576 2,41     8:   47,702,645 - 47,725,042 Caspase 3 (Casp3) [NM_009810]  
A_52_P68087 2,36     8:   48,072,279 - 48,180,249 Ectonucleotide pyrophosphatase/phosphodiesterase 6 (Enpp6) [NM_177304] 
A_51_P132530 2,3     8:   48,909,836 - 48,910,829 Mus musculus adult male stomach cDNA, Rik2210404A22 [AK008821] 
A_52_P351791 2,26     8:   72,142,768 - 72,149,444 Mus musculus 0 day neonate thymus cDNA, RikA430055D15 [AK079745] 
A_52_P553859 2,38     8:   74,200,195 - 74,214,474 Tyrosine-protein kinase JAK3  (Janus kinase 3) (JAK-3) [TC1539197] 
A_52_P835473  2,14   8:   91,562,636 - 91,565,980 Mus musculus 13 days embryo heart cDNA, RikD330014J04 [AK052259] 
A_51_P157081 2,43     8: 109,643,010 - 109,643,792 Mus musculus adult male hippocampus cDNA, RikC630050I24 [AK021281]   
A_52_P135282  2,04   8: 112,471,817 - 112,486,072 MARVEL (membrane-associating) domain containing 3 (Marveld3) [NM_212447]  
A_52_P611783 4,3     9:   45,207,957 - 45,218,361 FXYD domain-containing ion transport regulator 2 (Fxyd2) [NM_052824] 
A_52_P177021 2,07     9:   50,329,723 - 50,336,756 6-pyruvoyl-tetrahydropterin synthase (Pts) [NM_011220] 
A_52_P488572 4,22     9: 110,523,641 - 110,526,897 Engulfment and cell motility 1, ced-12 homolog (Elmo1) [NM_080288]  
A_52_P482055 2,04     X:   70,310,126 - 70,313,529 Paraneoplastic antigen MA3 (Pnma3) [NM_153169] 
A_51_P292146 2,14   10:     7,924,551 - 8,238,623 Uronyl-2-sulfotransferase (Ust) [NM_177387] 
A_51_P265374 2,03   10:   23,571,278 - 23,589,637 Vanin 3 (Vnn3) [NM_011979] 
A_52_P673043  2,11 10: 114,515,699 - 114,622,078 Tryptophan hydroxylase 2 (Tph2) [NM_173391] 
A_52_P907995 2,16   11:   75,556,521 - 75,558,910 Mus musculus 9 days embryo whole body cDNA, RikD030051F04  [AK083592] 
A_51_P175667  2,72 11:   87,619,930 - 87,639,617 Lactoperoxidase (Lpo) [NM_080420] 
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A_51_P379409  3,98 11:   87,912,751 - 88,006,408 CUE domain containing 1 (Cuedc1) [NM_198013] 
A_51_P324082  2,22 11:   98,014,028 - 98,054,607 Peroxisome proliferator activated receptor binding protein (Pparbp) [NM_013634] 
A_52_P37517  2,01 11:   99,084,313 - 99,085,778 Mus musculus adult male thymus cDNA, Rik5830412H02 [AK017922] 
A_52_P100156  2,12 11:   99,267,978 - 99,283,573 Keratin complex 1, acidic, gene 12 (Krt1-12) [NM_010661] 
A_51_P489138 2,06   12:   77,681,475 - 77,811,534 Spectrin beta 1 (Spnb1) [NM_013675] 
A_52_P682239 2,05   13:     8,202,124 - 8,206,010 Mus musculus 12 days embryo spinal ganglion cDNA, Rik130050D08 [AK051460] 
A_52_P628546 3,18   13:   21,605,091 - 21,622,989 Zinc finger protein 192 (Zfp192) [NM_139141] 
A_51_P505521 2,15   13:   22,132,492 - 22,133,189 Mus musculus cDNA clone UI-M-CC0-ayb-f-07-0-UI 5'. [BF467941] 
A_52_P67892 2,46   13:   23,710,085 - 23,712,947 Mus musculus, clone IMAGE:3465495 [BC032927] 
A_52_P660047 2,52   13:   64,350,054 - 64,369,453 Mus musculus adult male kidney cDNA, RikF530007I15 [AK143964] 
A_51_P470989  5,1 13: 120,217,407 - 120,249,127 Polyadenylate binding protein-interacting protein 1 (Paip1) [NM_145457] 
A_52_P212284  3,4 13: 120,217,407 - 120,249,127 Polyadenylate binding protein-interacting protein 1 (Paip1) [NM_145457] 
A_52_P603540  2,41 14:     6,956,283 - 6,964,644 Mus musculus Rik4930555G01 [NM_175393] 
A_51_P305239 2   14:   25,436,790 - 25,440,915 Mus musculus adult male testis cDNA, Rik4931403M11 [AK016429] 
A_52_P334499 2,08   16:   58,995,230 - 59,000,442 Olfactory receptor 183 (Olfr183) [NM_146485] 
A_52_P533250  2,5 16:   73,683,735 - 73,684,194 Mus musculus Rik1700041G16 [NM_175196] 
A_52_P314299 2,21   16:   91,465,349 - 91,470,366 Mus musculus adult male hypothalamus cDNA, RikA230049K01 [AK038602] 
A_52_P236288 5,32   16:   93,343,992 - 93,353,434 Mus musculus 10 day old male pancreas cDNA, Rik1810053B23 [AK007854] 
A_52_P447375  13,15 16:   93,608,082 - 93,610,594 Carbonyl reductase 1 (Cbr1) [NM_007620]  
A_52_P300533 2,09   16:   93,792,395 - 93,795,133 Mus musculus adult male tongue cDNA, Rik2310043M15 [AK009785] 
A_51_P236483  2,64 17:   24,035,699 - 24,056,407 Mus musculus cDNA sequence BC005655 [NM_145386] 
A_51_P201672  15,466 17:   25,073,247 - 25,074,281 Mus musculus adult male testis cDNA, Rik1700009P10 [AK005803] 
A_52_P680761  27,41 17:   43,752,288 - 43,767,248 Mus musculus tudor domain containing 6 (Tdrd6) [NM_198418]  
A_51_P320340 2,05   17:   47,047,434 - 47,061,875 Mus musculus retinal degeneration (Rds), mRNA [NM_008938] 
A_52_P405655 2,51   18:   81,163,115 - 81,183,317 Mus musculus sal-like 3 (Drosophila) (Sall3) [NM_178280] 
A_52_P159365 3,61   18:   81,163,115 - 81,183,317 Mus musculus sal-like 3 (Drosophila) (Sall3) [NM_178280] 
A_52_P843410 2,22   19:   35,098,034 - 35,100,114 Mus musculus 16 days neonate thymus cDNA, RikA130049N17 [AK037788] 
A_51_P277139 8,22   19:   50,614,297 - 50,615,375 Mus musculus adult male testis cDNA, Rik4933436E20 [AK017078]  
A_52_P119039 2,03   not placed Mus musculus 15 days embryo male testis cDNA, Rik8030402P03 [AK078743] 
A_52_P125897 2,12   not placed Mus musculus cDNA clone IMAGE:5039788 [BI107100] 
A_52_P597818 2,89   not placed Mus musculus cDNA sequence AF067063 [NM_001001449] 
A_52_P129428 5,13   not placed Mus musculus 16 days embryo head cDNA, RikC130058L18 [AK048420] 
A_51_P317562 2,07     Unknown 
A_52_P14506 2,12     Unknown 
A_52_P616932 2,23     Unknown 
A_52_P1141541 2,31     Unknown 
A_51_P338963 2,61     Unknown 
Table 3.3: Differentially expressed mRNAs in testes of 18 days old Tdrd6-/- mice are listed, sorted by their 
genomic localization. The accession numbers, fold change and genomic loci are listed. Highlighted in grey are all 
mis-regulated genes on chromosome 1 and 8. 
 
 
Figure 3.17: Genomic distribution of all differentially expressed genes in the testes of 18-days-
old Tdrd6-/- mice. 36 % of the genes are located on Chr 8, and 11 % are located on Chr 1. The 
threshold was set to 2-fold up- or down-regulated and the P-value was set to 0.05.  
Results  56   
              
Randomly four genes from chromosome 8 were chosen; three of the most up-
regulated genes (Fgl1, Rik4933404M01 and Rik1700104B16) and the most down-
regulated gene (Zfp42), and the tendency of their mis-regulation in Tdrd6-/- mice was 
significantly confirmed by quantitative real time PCR (figure 3.18).  
 
Figure 3.18: Differentially expressed genes in testes of Tdrd6-/- mice. Analysis was performed with 
total testis RNA from 18 days old Tdrd6+/- and Tdrd6-/- mice. The values for the Tdrd6+/- control were 
set to 1.0 and the respective increase or decrease in Tdrd6-/- mice are represented as mean +/- SEM 
(standard error mean). (*** P value <0.001, ** P value 0.001 to 0.01, * P value 0.01 to 0.05; ns, not 
significant P value >0.05). 
 
 
Some of the mis-regulated genes play roles in carcinogenesis. Zinc finger protein 42 
(ZFP42), also called Rex-1, is a transcription factor responsible for stem cell potency, 
which was described to be strongly expressed in human spermatocytic seminomas 
(Jessberger 2008; Kristensen et al. 2008). Zfp42 is 48-fold down-regulated in Tdrd6-
deficient mice. Fibrinogen-like 1 (FGL1) is a liver-specific gene that is frequently 
down-regulated in hepatocellular carcinoma (Yan et al. 2004). It is described as a 
tumour-suppressor gene on the short arm of human Chr 8. The mouse Fgl1 mRNA is 
6,7-fold up-regulated in the Tdrd6-deficient mice. Inhibitor of kappaB kinase epsilon 
(IKBKE) has been recently identified as an oncogene, which is frequently 
overexpressed in ovarian cancer cell lines (Guo et al. 2009). Ikbke is localized to the 
long arm of Chr (1q12) and is 2-fold down-regulated in the Tdrd6-/- mice.  
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The observation that 36 % of all mis-regulated genes are located on Chromosome 8 
and 11 % on chromosome 1 was very surprising, since nothing is known about the 
effect of TDRD6 on particular chromosomes. TDRD6 has not been seen in the nuclei 
of cells, and thus a direct effect on regulation of Chr 1 or Chr 8 is unlikely. An indirect 
influence of TDRD6 would be possible through common promoter features all of mis-
regulated genes, e.g. transcription factors (TF). To analyze putative TF of all 
differently expressed genes, bioinformatic analyses were done using the MAPPER 
database. This program predicts all hypothetical TF binding sites (TFBSs) in the 
promoter region of certain genes by comparing sequence homology. 
We analyzed 25 mis-regulated genes, as well as five control genes, which are not on 
Chr 8 (Tdrd6, Chr 17; Pax4, Chr 6; Cldn14, Chr 16) or are localized to the same 
region of Chr 8, but are not mis-regulated (Tusc3, Rnf122) in the microarray analyses 
of the Tdrd6-/- mice. The promoter region within 2000 bp upstream of the start codon 
of each gene was analyzed. For all genes more than 600 predicted binding sites for 
transcription factors were found, most of the TF showed more than one hit. All mis-
regulated genes had 35 putative transcription factors in common (Table 3.4). The aim 
was to identify transcription factors that regulate only the differently expressed genes 
in the Tdrd6-/- mice. When comparing the results of the TF binding site analyses from 
the mis-regulated genes with the control genes, no transcription factor was found that 
was specific for the mis-regulated genes. Three transcription factors (Freac-4, Nrf2 
and SU_h) revealed binding sites in the promoter region 2000 bp upstream of the 
start codon in all 25 mis-regulated genes, but were missing in the promoter region of 
one of the control genes. So far, we cannot conclude anything about possible 
regulation through any of these transcription factors, since all of them are present in 
at least 4 of 5 control genes.  
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Trancription 
factor 
mis- 
regulated 
genes 
Ctrl gene 
Tusc3 
Ctrl gene 
Rnf43 
Ctrl gene 
Rnf122 
Ctrl gene 
Pax4 
Ctrl gene 
Cldn14 
AML1 √ √ √ √ √ √ 
Androgen √ √ √ √ √ √ 
Athb-1 √ √ √ √ √ √ 
Broad-compl_1 √ √ √ √ √ √ 
c-ETS √ √ √ √ √ √ 
COUP-TF √ √ √ √ √ √ 
Dof 2 √ √ √ √ √ √ 
Dof 3 √ √ √ √ √ √ 
Dorsal_2 √ √ √ √ √ √ 
Evi-1 √ √ √ √ √ √ 
FREAC-4 √ √ √ √ – √ 
HFH-1 √ √ √ √ √ √ 
HFH-2 √ √ √ √ √ √ 
HMG-IY √ √ √ √ √ √ 
IRF-2 √ √ √ √ √ √ 
MEF2 √ √ √ √ √ √ 
Myc-Max √ √ √ √ √ √ 
MZF_5-13 √ √ √ √ √ √ 
NF-1 √ √ √ √ √ √ 
Nkx √ √ √ √ √ √ 
Nrf2 √ – √ √ √ √ 
Pax-2 √ √ √ √ √ √ 
PPAR gamma √ √ √ √ √ √ 
RORalfa-1 √ √ √ √ √ √ 
RREB-1 √ √ √ √ √ √ 
Sox-17 √ √ √ √ √ √ 
Sox-5 √ √ √ √ √ √ 
Sox-9 √ √ √ √ √ √ 
SPI-B √ √ √ √ √ √ 
Spz1 √ √ √ √ √ √ 
SQUA √ √ √ √ √ √ 
SRY √ √ √ √ √ √ 
Staf √ √ √ √ √ √ 
SU-h √ – √ √ √ √ 
Thing1-E47 √ √ √ √ √ √ 
Table 3.4: Common putative transcription factor binding sites of 25 mis-regulated genes of the 
Tdrd6-/- mice mRNA analyses and their abundance in 5 control genes. As a control, two not mis-
regulated genes from the same centromer-proximal region on Chr 8 were chosen (Tusc3, Rnf122) and 
three genes from other chromosomes. Three TF are highlighted in grey because they do not bear 
hypothetical binding sites in one of the control genes.  
 
 
Using the miRDB database, one can search for hypothetical miRNAs, which can bind 
to mRNAs of interest. Analyses for 52 known proteins, which are mis-regulated in the 
Tdrd6-/- mice, were performed. Unknown mis-regulated cDNAs from the microarray 
analyses could not be investigated by this database. Table 3.5 shows all investigated 
mis-regulated mRNAs in the Tdrd6-deficient mice, which found complementary hits in 
the database analyses. MiRNAs are listed, which can hypothetically target these 
mRNAs, and are also mis-regulated in the Tdrd6-/- mice. For 16 mRNAs 
corresponding miRNAs could be found.  
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Probably not all miRNAs are indeed responsible for the mis-regulation of the listed 
mRNAs in vivo, but these are first hints of possible regulations, which have to be 
investigated thoroughly.  
 
 
mRNA miRNA (mmu-) 
Agpat5 miR-470 
Cdh20 miR-30e, miR-200b 
Elmo1 miR-742 
Fbln2 miR-128 
Fgl1 miR-26b 
Fut10 miR-494, miR-712 
Lep miR-200a 
Lpo miR-467a 
Marveld3 miR-19a 
Pam miR-743b, miR-881 
Sall3 miR-301a 
Sfrp1 miR-466b-3-3p 
Slc7a2 miR-15a, miR-322, miR-466a-3p, miR-466b-3-3p, miR-497 
Wrn miR-203, miR-204 
Zfp42 miR-465a-5p, miR-465b-5p 
Zfp192 miR-19a, miR-83b-3p, miR-128, miR-140, miR-301a, miR-203, miR-351, miR-466a-3p, 
miR-466b-3-3p, 743b-3p 
Table 3.5: Database analyses using miRDB database. Analyses revealed hypothetical matches 
between differently expressed mRNAs and mis-regulated miRNAs in Tdrd6-/- mice. 
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4. Discussion 
 
As described previously (Vasileva et al. 2009), TDRD6 is a male germ cell specific 
protein and two different isoforms are expressed. The 250 kDa isoform is expressed 
in spermatocytes, the smaller isoform (230 kDa) mainly in round spermatids and 
localizes to the chromatoid body. Due to sequence analysis we hypothesize, that 
TDRD6 gets cleaved by Caspase I at the C-terminal end. So far, we could confirm 
that the cleavage takes place at the C-terminus, but still no details about the process 
of cleavage itself or the biological purpose are known. One interesting finding by our 
group is, that not only the full length TDRD6, but also a deletion mutant, where the 
approximately 20 kDa C-terminal end is missing, interact in direct in vitro protein 
interaction experiments with MILI and MIWI (Vasileva et al. 2009). This leads to the 
hypothesis, that both forms may affect MILI and MIWI localization and function.   
The newly generated Tdrd6-deficient mice are normal, healthy mice, except their 
severe defects in spermatogenesis. Due to the absence of mature sperm, the mice 
are sterile. Since TDRD6 is not expressed in female mice, females do not show any 
abnormalities. The increase in apoptotic cells, which was observed in the first wave 
of spermatogenesis around day 19, is most probably due to overall changes in 
mRNA and miRNA expression patterns in the Tdrd6-deficient mice.  
The Tdrd6-/- germ cells apparently develop normal until the transition from round to 
elongated spermatids, where an arrest between step 12 and 13 occurs. Due to 
defects in the chromatoid body assembly, the cells cannot go further in their 
maturation process. Chromatoid bodies in Tdrd6-/- mice are diffuse, disrupted and 
less condensed than their counterpart in wild-type mice. Tdrd6-/- CBs are in the same 
close proximity to the nuclear membrane and do not differ in their total size. But their 
interior is largely missing, and only a “ghost”-like structure remains. CBs exhibit 
defects in recruiting proteins, which are known to localize to this compartment. In 
Tdrd6-/- testis sections, proteins like MVH, MIWI and MAEL are expressed, but do not 
localize to the CB in round spermatids, which leads most probably to the disrupted 
appearance. We (Vasileva et al. 2009) and others (Hosokawa et al. 2007) showed 
that TDRD6 directly interacts with CB proteins like MVH, MILI and MIWI, and has 
most probably a role in building complexes and scaffolds. Tudor domain proteins are 
known to be involved in scaffolding through their tudor domains (Hirose et al. 2000; 
Hosokawa et al. 2007; Skorokhod et al. 2008). Since in the Tdrd6-/- mice all seven 
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tudor domains of TDRD6 are deleted, it is not unexpected, that Tdrd6-/- spermatids 
are not able to assemble the chromatoid body correctly. 
In the literature (Ventela et al. 2003) it was described, that the chromatoid body 
moves within the cell, as well as through cytoplasmic bridges between spermatids. It 
would be interesting to investigate, if the CBs in the Tdrd6-/- spermatids are still able 
to move or if they are immobile due to their disrupted phenotype.  
Chromatoid bodies play a role in extensive posttranscriptional storing and processing 
of mRNAs in male germ cells, due to involvement of small RNAs like microRNAs 
(miRNAs) and Piwi-interacting RNAs (piRNAs) (Kotaja and Sassone-Corsi 2007). 
Since in Tdrd6-/- mice the CB is not completely functional we investigated, whether 
miRNAs in testes show an altered expression profile. Indeed, approximately 10 % of 
all known miRNAs in mice were shown to be differently expressed in testes of   
Tdrd6-/- mice, with most of the miRNAs up-regulated. Since we observed an up-
regulation of microRNA precursors as well, we can conclude, that transcription of 
miRNAs directly is affected. 
An interesting question is, if miRNA precursor can be exported to the CB. Nothing is 
known, if the precursors remain in the nucleus, or are transported to the cytoplasm of 
the cell by mistake. So far, we analyzed only the expression of mature miRNAs from 
total testes RNA. Further analyses, e.g. in situ hybridization using probes for specific 
miRNAs, would be helpful to get information about the localization of mature 
miRNAs. Not only the mature transcripts of three investigated miRNAs are up-
regulated, but also the corresponding precursors. An assumption would be, that 
TDRD6 plays an unexpected direct role in transcriptional regulation of miRNA gene 
expression, but since TDRD6 has not been seen in nuclei of cells, it is more likely 
due to an indirect effect of TDRD6, probably through a common transcriptional 
regulation by transcription factors (TFs). One hypothesis would be, that the 
responsible TFs are mis-regulated because of the disrupted CB itself. Pri-miRNAs 
are typically transcribed by RNA polymerase II or III and have promoter elements that 
are similar to those of protein-coding genes, a TATA box, CpG islands and a 
transcriptional start site (Cui et al. 2009). Promoter analyses of all investigated mis-
regulated miRNA genes in the Tdrd6-deficient mice, did not reveal any common 
features, like transcription factors, transcriptional start sites or CpG islands. 
Furthermore, no similarities were found between all mis-regulated miRNAs in respect 
to their localization either intergenic or intronic in the genome. Since these analyses 
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were done with bioinformatic databases, which work on the basis of sequence 
homology, we cannot conclude about the real situation in the cell and possible 
common features, which are not detected by databases. 
MiRNA genes lie in cluster of several genes on the chromosomes. Interestingly, not 
all miRNAs from one cluster are differently expressed. For example, only 9 of 13 
miRNAs from one cluster on chromosome X, and only 3 of 8 miRNAs from a cluster 
of Chr 2, are up-regulated. The remaining miRNAs of these clusters are not affected. 
This supports either the hypothesis that miRNA genes within one cluster can be 
differently expressed (Song and Wang 2008), or the remaining miRNAs were not 
detected by any reason during the microarray analyses. One third of all mis-regulated 
miRNAs in Tdrd6-/- mice are located on Chr X. This chromosome is known to be rich 
in miRNAs specific for male germ cells, 19 % of all known mouse testis miRNAs are 
located to this chromosome (Ro et al. 2007b).  
Through database analyses hypothetical targets can be predicted due to sequence 
homology between mature miRNA and mRNA. For each investigated miRNA more 
than 500 hypothetical target mRNAs are predicted. Several families of miRNAs are 
aberrantly regulated, including the miR-29, miR-34, and miR-463 families. The 
predicted targets of these miRNAs generally include many testis-specific RNAs. 
Interesting mRNA candidates could be investigated e.g. by immunoblotting, if the 
according protein is aberrantly expressed in the Tdrd6-/- mouse. 
Vice versa, when analysing the mis-regulated mRNAs of the Tdrd6-deficient mouse 
for hypothetical sequence homology to all differently expressed miRNAs, matches for 
16 mRNAs could be found. All listed miRNAs are up-regulated in the Tdrd6-deficient 
mouse. If a mature miRNA were more abundant in a cell, the corresponding target 
would be down-regulated. But some of the listed mRNAs are up-regulated in the 
Tdrd6-/- mouse (Agpat5, Cdh20, Elmo1, Fbln2, Fgl1, Fut10, Lep, Sall3, Slc7a2, Wrn 
and Zfp192). We have to take in consideration, that these results are just 
theoretically, based on sequence homology. Probably not all miRNAs are indeed 
responsible for the mis-regulation of the listed mRNAs in vivo, but these are first hints 
of possible regulations.  
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In the Tdrd6-deficient mouse, 36 % of all differently expressed genes are located in 
the centromer-proximal region of chromosome 8, and 11 % of the genes on the distal 
end of chromosome 1. Nothing is known so far about TDRD6 and its possible role in 
transcriptional regulation of specific chromosomes. Since it has not been seen in the 
nucleus itself, there is likely some indirect influence of TDRD6. One control 
experiment would be to investigate if the Tdrd6-/- mice exhibit rearrangement on Chr 
1 or Chr 8 due to some undesirable effects. Chr 8 is a chromosome in the mouse 
genome where rearrangements seem to occur most frequently. Chr 8 trisomy is one 
of the most frequent abnormalities occurring in ES cell lines (Liu et al. 1997), and 
pericentric inversions have been reported (Ashley et al. 1993). A large repeated 
region has been identified in laboratory strains of mice, which comprises 60 to 80 
copies of a partially characterized element. Most of these copies are clustered in the 
pericentromeric region of mouse Chr 8 (Boyle and Ward 1992).  
To rule out the possibility of unspecific effects of chromosomal rearrangements, one 
has to analyze, if rearrangement occurred in the embryonic stem cells, due to some 
unknown reasons. One possible method to analyze the chromosomal structure in 
Tdrd6-/- mice is fluorescence in situ hybridization (FISH), using probes for specific 
regions on Chr 1 and 8. If the chromosomal structure of all Tdrd6 progenies would be 
normal like in wild-type mice, one could conclude, that the phenotype of mis-
regulated genes on Chr 1 and 8 is indeed due to the disruption of Tdrd6. One 
argument against the hypothesis of rearrangement in the ES cell clone is, that the 
obtained chimeras were crossed with different wild-type mice and within the mouse 
colony for more than five generations, before microarray analyses were done. In this 
analyses Tdrd6+/- and Tdrd6-/- mice from different breeding pairs were investigated 
and only the Tdrd6-deficient mice showed the “chromosome 1 and 8” phenotypes. 
Thus, it is more likely that this phenotype is indeed caused by the disruption of the 
Tdrd6 gene.  
One possible mechanism of mis-regulation of all genes on both chromosomes would 
be through common transcriptional regulations. Promoter analyses considering their 
transcription factor binding sites (TFBS) of 25 mis-regulated genes were performed, 
and 35 common transcription factors were found. When comparing the results of the 
TF binding site analyses from the mis-regulated genes with the control genes, no 
transcription factor was found that was specific for the mis-regulated genes. So far, 
we cannot conclude a mechanism of common transcriptional regulation of the 
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differently expressed genes in the Tdrd6-deficient mice. Further analyses have to be 
done, e.g. analyses of the expression pattern of certain transcription factors in the 
Tdrd6-/- mice. Chromatin-Immunoprecipitation (ChIP) would give information about 
direct binding of TFs to the promoter region of mis-regulated genes in the Tdrd6-
deficient mice. 
The affected regions on Chr 1 and 8 in the Tdrd6-/- mouse are orthologous to regions 
on the human chromosomes 1 and 2, as well as the short arm of the human 
chromosome 8 (Figure 4.1).  
 
 
Figure 4.1: Presented are the mouse chromosomes 1 and 8 and their orthologous regions on 
the human chromosomes 1, 2, and 8. Encircled are the regions with the highest number of mis-
regulated genes. 
 
 
In a variety of human malignancies, aberrations and loss of heterozygosity (LOH) of 
human chromosomes are common. The most common chromosomal abnormalities 
are gains at 1q (q, long arm), 7p (p, short arm), 7q, 8q, and Xq, and losses at 8p, 
10q, 13q, and 16q. The frequent rearrangement of chromosome band 1q12 
constitutive heterochromatin in hematologic malignancies suggests that this 
rearrangement plays an important role in these diseases. The oncogenic 
mechanisms linked to 1q12 heterochromatin are unknown. Constitutive 
heterochromatin can epigenetically regulate gene function through the formation of 
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transcriptional-silencing compartments (Barki-Celli et al. 2005). Methylation studies of 
carcinomas of breast, liver and ovary have revealed an association between 
hypomethylation of this heterochromatic region on the long arm of chromosome 1 
(1q12) and rearrangement within this region (Davidsson et al. 2007).  
Genomic deletions involving the short arm of the human chromosome 8 are common 
in a wide range of epithelial malignancies including prostate (Macoska et al. 1994; 
Kagan et al. 1995), colorectal (Emi et al. 1992), breast (Yokota et al. 1999), and 
bladder (Takle and Knowles 1996; Wagner et al. 1997) carcinomas. In many of these 
cancer types, loss of heterozygosity is associated with a more aggressive tumour 
phenotype indicating the possible presence of a tumour suppressor (Knowles et al. 
2005). An interesting rearrangement on Chr 8 in a human primary giant cell 
carcinoma of the lung is the joining of a LINE-1 family member to the 5’- upstream 
region of the c-myc gene (Iizuka et al. 1990). In breast cancer two regions at 8q11-
q12 and 8q23-24 are commonly deleted (Dahiya and Deng 1998). Alterations of 
chromosome 8 are found in up to 50 % of prostate cancers (Schulz et al. 2007). 
Several genes located on chromosome 8p have been examined as candidate tumour 
suppressors, with one of the most promising being c-Myc (DeMarzo et al. 2003).  
Fgl1 (fibrinogen-like 1) is a tumour-suppressor gene on the short arm of human Chr 
8, which down-regulation in hepatocellular carcinoma is frequently associated with 8p 
allelic losses. Surprisingly, we found the mouse Fgl1 mRNA up-regulated in the 
Tdrd6-deficient mice. Oncogenes like Inhibitor of kappaB kinase epsilon (Ikbke) and 
Zinc finger protein 42 (Zfp42) were shown to be down-regulated in the Tdrd6-/- mice.  
These are not the only indications, that TDRD6 might play an unknown role in 
carcinogenesis. The human TDRD6 was initially found to be expressed in colon 
carcinoma cells (Scanlan et al. 2002). Meiosis/germ cell-specific genes like Sycp3 
are known, to cause cell transformation, when they are overexpressed in somatic 
cells (Adamah et al. 2006; Jessberger 2008). MiRNAs like the miR-34 family are 
known to play a role in tumorigenesis, by directly targeting the p53 tumour 
suppressor gene (He et al. 2007). The miR-34 family is up-regulated in the Tdrd6-/- 
mice. But if TDRD6 indeed plays a role in somatic carcinogenesis, possibly through 
mis-regulation of certain miRNAs, will be investigated in more detail, e.g. by 
screening different human tumour tissues for the expression of the mouse TDRD6. 
An antibody against the N-terminus of TDRD6 will be used, to detect both isoforms of 
the protein. 
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In many human cancers, the overall level of DNA cytosine methylation is decreased, 
even though specific sites may be hypermethylated (Robertson 2001). The increase 
in DNA methylation affects different types of repetitive sequences, such as 
retrotransposons and satellites, which contain most of the methylcytosines in the 
genome (Schulz 1998). At the same time that CpG islands become hypermethylated, 
the genome of the cancer cell undergoes a dramatic global hypomethylation. 
Although some cancer specimens seem to retain an overall DNA methylation level 
close to that of normal tissue, some show extensive hypomethylation, with up to        
50 % decrease in an overall methylation. Pronounced global hypomethylation is 
associated with chromosomal instability in several human cancer types. For example 
the alterations on human chromosome 8 in prostate carcinoma, which were found to 
correlate with diminished methylation of repetitive LINE-1 sequences (Ehrlich 2002; 
Schulz et al. 2002). These sequences are highly methylated in normal somatic tissue 
including prostate. In the Tdrd6-/- mice no modified methylation pattern in the Line-1 
promoter region in comparison to wild-type mice was observed. This was in contrast 
to other chromatoid body components, like MIWI2, MILI and MAEL, which are known 
to be involved in transposon activation through methylation of CpG islands in the 
promoter region. This indicates that, despite malformed CBs and mislocalization of 
MIWI, MVH, and MAEL, protection from retrotransposons activation is still functional. 
And it emphasizes the assumption that TDRD6 may represent a new class of CB 
proteins, specifically involved in CB formation and small RNA transcription and 
processing.  
If other genes in the Tdrd6-deficient mouse show abnormal methylation pattern in 
their promoter region, will be investigated in more detail, e.g. by bisulfite sequencing 
analyses of some mis-regulated genes in the Tdrd6-/- mouse, especially the genes on 
chromosomes 1 and 8. 
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5. Summary 
 
Several tudor domain proteins exists in mammalian germ cells. We are interested in 
the male germ cell specific tudor domain containing protein 6 (TDRD6). It is 
composed of seven characteristic tudor domains, which are known to bind nucleic 
acids (mostly RNA), as well as some arginine-methylated proteins. Tudor domain 
containing proteins are suggested to build macromolecular complexes or scaffolds, 
through binding with their tudor domains. TDRD6 expression starts around day 16 in 
spermatogenesis, from primary spermatocytes to round spermatids. It exists as two 
different isoforms, in spermatocytes as a 250 kDa protein, and after development of 
the cells into haploid spermatids, as a prominent 230 kDa protein. Using two different 
antibodies against each terminus, we observed that the protein gets cleaved at the 
C-terminal end, possibly through Caspase I. In round spermatids TDRD6 is localized 
to the chromatoid body (CB), a male germ cell specific, electron-dense structure. It is 
in close proximity to the nucleus, and makes frequent contact with the nuclear pores, 
where an extensive exchange of material between nucleus and CB occurs. The CB 
consists mainly of RNA and various RNA-binding proteins, as well as small non-
coding RNAs like microRNAs (miRNAs) and Piwi-interacting RNAs (piRNAs). These 
small non-coding RNAs behave as sequence-specific triggers for degradation and 
translational repression of mRNAs, which are stored in the CB. MiRNAs exist in 
clusters on the chromosomes and are transcribed into precursor miRNAs. They are 
exported into the CB, where they are processed into mature miRNAs. Mature 
miRNAs are incorporated into the RNA-induced silencing complex (RISC), which can 
regulate the translation of mRNAs. Chromatoid body components like MIWI, MIWI2 
and MILI, all belonging to the Piwi protein family, are known to bind another class of 
small non-coding RNAs, the Piwi-interacting RNAs. These testis-specific RNAs are 
important to regulate transposon activity during germ cell development. 
To analyze the function of TDRD6 during male germ cell development, a Tdrd6-
deficient mouse model was generated, by disrupting most of exon 1, which implies 
deletion of all seven tudor domains and thus, leading to complete absence of 
TDRD6. The Tdrd6-deficent mice are viable and healthy, whereas the male mice are 
sterile, due to absence of mature sperm. The female mice are not affected, since 
TDRD6 is not expressed in females. The most striking intracellular phenotype of  
Tdrd6-/- mice is their highly aberrant architecture of chromatoid bodies in round 
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spermatids. Tdrd6-/- CBs appear as diffuse, disrupted, and less condensed 
structures. Their interior is largely missing, and only a “ghost”-like structure remains, 
expected to be significantly impaired in function. Other CB components like MVH, 
MIWI and MILI are expressed in Tdrd6-/- testes, but they cannot localize to the 
disrupted CBs. This suggests a role for TDRD6 in assembling the chromatoid body 
complex by recruiting other proteins. We investigated if the maintenance and 
processing of small RNAs is affected in the disrupted CB of the Tdrd6-/- mice. 
Approximately 10 % of all known murine miRNAs are differently expressed in Tdrd6-
deficient mice, whereas most of the miRNAs are up-regulated, indicating less 
turnover, and thus, accumulation of mature miRNAs. But not only the mature 
miRNAs are differently expressed, also three investigated miRNAs showed abnormal 
expression of precursors. This leads to the assumption that TDRD6 most likely has 
an influence on transcriptional regulation of miRNA genes, most likely by an indirect 
effect, probably through transcriptional regulation. No common features in the 
promoter region of the investigated mis-regulated miRNAs were observed.  
The chromatoid body in the Tdrd6-deficient mice is disrupted and seems to be not 
functionally. Since it is a place for mRNA storage and regulation, it was interesting to 
analyze, if testes cells show an abnormal expression pattern. In the Tdrd6-/- testes 
more than 100 genes are differently expressed. Unexpectedly, 36 % of all genes are 
located to the centromer-proximal region of Chr 8, and 11 % are located to the distal 
end of Chr 1. These regions are orthologous to regions on human chromosomes, 
which show an altered chromosomal structure in many different carcinomas, due to 
rearrangements and loss of heterozygosity. Genes like Fgl1, Zfp42 and Ikbke, which 
are known to play a role in carcinogenesis, are differently expressed in the Tdrd6-/- 
mouse. Additionally, miRNAs like miR-34 and miR-29 are known to be involved in 
tumorigenesis and are mis-regulated in the Tdrd6-deficient mice. One possibility for 
mis-regulation of genes is transcriptional regulation through transcription factors (TF). 
Database analyses revealed no common TFs, which are specific for mis-regulated 
genes on Chr 8, as well as differently expressed genes from other chromosomes. 
Another possibility is, that mis-regulated miRNAs directly target specific mRNAs, and 
thus, leading to differently expression of them. Using database analyses, putative 
homologous miRNAs were found for 16 of the mis-regulated genes. These findings 
have to be analyzed in more detail.  
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In the Tdrd6-/- mice no modified methylation pattern in the Line-1 promoter region 
was observed in comparison to wild-type mice. This was in contrast to other 
chromatoid body components, like MIWI2, MILI and MAEL, which are known to be 
involved in transposon activation through methylation of CpG islands in the promoter 
region. This highlights again, that TDRD6 may have a distinct role in germ cell 
development than other CB components. Whereas others regulated transposon 
activity, TDRD6 seems to have a scaffolding function and is important for the correct 
assembly of the chromatoid body, as well as small RNA transcription and processing. 
If TDRD6 plays any role in carcinogenesis will be investigated further in more detail. 
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7. Abbreviations 
 
aa   amino acids 
AE   axial element 
bp   base pair 
CB   Chromatoid body 
cDNA   complementary DNA 
Chr   chromosome 
Cy3   Cyanine-3 
DAPI   4’,6-diamidino-2-phenylindole 
DNA   deoxyribonucleic acid 
dpc   days post coitum 
dpp   days postpartum 
e.g.   for example 
ES   embryonic stem (cells) 
FITC   Fluorescein isothiocyanate 
GST   Glutathione S-transferase  
h   hours  
HRP   Horseradish peroxidase 
hs   homo sapiens 
i.e.   id est (that is)  
kb   kilo base  
kDa   kilo Dalton 
kg   kilogram 
LTR   long terminal repeat 
min   minutes 
miRNA  microRNA 
mg   milligram 
ml   milliliter 
mm   mus musculus 
mRNA  messenger ribonucleic acid 
nm   nanometer 
ng   nanogram 
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nt   nucleotide 
ORF   open reading frame 
PCR   polymerase chain reaction 
PGCs   primordial germ cells 
piRNA   piwi-interacting RNA 
pre-miRNA  preliminary miRNA 
pri-miRNA  primery RNA 
qRT-PCR  quantitative real time polymerase chain reaction 
rasiRNA  repeat associated RNA 
RISC   RNA induced silencing complex 
RNA   ribonucleic acid 
RT   room temperature 
SC   synaptonemal complex 
SDS-PAGE  sodium dodecyl sulfate polyacrylamide gel electrophoreses 
Sec   second 
siRNA   small interfering RNA 
UTR   upstream translational region  
UV   ultraviolet  
vol   volume 
µg   microgram 
µl   microliter 
µm   micrometer  
x g   x-fold g-force 
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8. List of chemicals 
 
Reagents Provider Cat #  
100 bp DNA ladder New England Biolabs N3231L  
100 mM dNTP Set  Invitrogen 10297-018  
Accustain Harris Hematoxylin Sigma-Aldrich HHS16-500ML  
Acetic acid (Glacial) Merck 1.000.631.011  
Acetone Merck 1.000.141.011  
Agarose Sigma A9539-500G  
Albumin Bovine (BSA) Sigma A2153-100G  
Ammonium sulfate Roth 3746.1  
APS Ammoniumperoxosulfate Roth 9592.3  
Bacto Yeast Extract BD 212750  
BioNickTM Labeling System  Invitrogen  18247-015  
Boric acid VWR 20.185.297  
Bouin's solution Sigma HT10132-1L  
Comassie Brilliant Blue  Merck 12553  
Bromphenolblue  Fluka 273997  
Calcium chloride Merck 1.023.821.000  
Chloramphenicol Sigma C0378-100G  
Chloroform Roth 3313.1  
Colchicine Sigma C9754-1G  
Collagenase type I Gibco 9001-12-1.  
Cot-1 DNA mouse Invitrogen 18440-016  
Cyanogen bromide-activated-SepharoseR 4 Fast Flow Sigma C5338-10G  
DAPI (Diamidine-2-phenylindole) dihydrochloride  Sigma D9542  
Deoxycytidine 5'-triphosphate (a-32P), 250µCi (9.25 MBq) PerkinElmer NEG013H250UC  
Deoxyribonucleic acid single stranded Salmon sperm testes Sigma D9156-1ML  
DEPC Diethyl Pyrocarbonate Sigma 1609-47-8  
Dextransulfate sodium salt Sigma D8906-10G  
Dimethyl sulfoxide Sigma D5879-100ML  
DMEM + GlutaMAX Invitrogen 31966-021  
DNA Molecular Weight Marker X Roche 11498037001  
DNase I Promega M610A  
DTT 1,4-Dithiothreit Roth 6908.3  
ECL Western Blotting  Pierce 1859701  
 Enzymes (PvuI, EcoRI, KpnI BglII, MspI, HpaI, HindIII) NEB    
Ethanol VWR 2 0821296  
Ethidium Bromide Merck 1.116.080.030  
Ethylenediaminetetraacetic acid (EDTA) Sigma E5134-500G  
Fetal calf serum (FCS) Invitrogen 10270-106  
Fixogum Marabuwerke 290117000  
Fluoromount-GTM Southern Biotech 0100-01  
Formaldehyde Sigma F8775-500ML  
Formamide, deionized Sigma F9037-100ML  
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Freund's Adjuvant, Complete Sigma F5881-10ML  
Freund's Adjuvant, Incomplete Sigma F5506-10ML  
FISH Gelatin from cold water fish skin Sigma G7765-250ML  
Glutathione reduced Sigma G4251-10G  
Glutathione-Agarose Sigma G4510-10ML  
Glycerol Roth 3783.1  
Glycine Sigma G8898-1KG  
HBSS Invitrogen 24020-091  
HEPES Gibco 15630-056  
Hoechst No.33342  (bisBenzimide) Sigma B-2261-100MG  
HybondTM-C super Amersham RPN203E  
HybondTM-N+ Amersham RPN203B  
Hydrochloric acid 37% Merck 1.003.171.000  
Igepal CA630/ NP-40 Fluka 56741  
Illustra Nick columns Amersham 17-0855-01  
IPTG Isopropyl ß-D-1-thiogalactopyranoside Peqlab 37-2020  
Isopropanol Merck 1.096.341.011  
Magnesium sulfate Sigma M8266-1KG  
Methanol Merck 1.060.091.011  
Milk Powder nonfat dried AppliChem A0830-0500  
Paraformaldehyde Sigma P6148-500G  
PBS Phosphate buffered saline  BioChrom AG L 18205  
Penicillin/Streptomycin BioChrom A2213  
Perfect HybTM Plus Hybridization buffer  Sigma H7033-125ML  
Periodic acid Pharmacy    
PMSF phenylmethanesulphonylfluoride Sigma P7626-5G  
Ponceau red Roth 5938.2  
Potassium acetate Sigma P1190  
Potassium dihydrogen phosphate Sigma P5655  
Potassium chloride Roth 6781.1  
Precision Plus ProteinTM Standard Bio-Rad 161-0373  
Prestainded marker Fermentas SM0671  
Prime It® RmT Random Primer Labeling Kit  Stratagene 300392  
Primer p(dT)15 for cDNA synthesis Roche 10814270001  
Propidium iodide Sigma P4170-25MG  
Protease Inhibitor Cocktail Complete Mini Roche 11836153001  
Protein A Agarose Invitrogen 15918-014  
Proteinase K Peqlab 04-1070  
Puromycin Sigma P7255   
QuantiTectR SYBRR Green PCR Kit Qiagen 204143  
Random Primers Promega C1181  
RNase A Sigma R4875-100MG  
Roti-Histokitt II  Roth T160.1  
Roti-Phenol Roth 0038.1  
Rotiphorese Gel 30 Roth 3029.2  
Roti-Quant Roth K015.1  
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RPMI 1640 Invitrogen 21875-034  
Schiff’s Reagent  Pharmacy    
SDS Sodium dodecylsulfate Roth 2326.2  
Sodium Azide Sigma  S8032  
Sodium Chloride Roth 3957.1  
Sodium citrate Fluka 71406  
Sodium deoxycholate Sigma G6750-100G  
Sodium DL-lactate Sigma L4263-500ML  
Sodium fluoride Sigma S7920  
Sodium hydroxid Sigma S8045  
Sodium metabisulfite Fluka 71928  
Sodium hydrogen phosphate Na2HPO4 Roth P030.2  
Sodium Orthovanadate Sigma S6508-10G  
Sodium Pyruvate Gibco 11360  
Sodium thiocyanate Fluka 71938  
ß-ME mercaptoethanol Sigma M6250-100ML  
Super Script TM II Reverse Transcriptase Invitrogen 18064-022  
TACSTM 2 TdT In Situ Apoptosis Detection Kit  Trevigen 4810-30-K  
Taq DNA Polymerase  Invitrogen 10342-020  
TEMED Bio-Rad 161-0801  
Tissue Tek O.C.T.TM Compound  Sakura 623010015  
TLCK Tosyl-L-Lysine chloromethyl ketone hydrochloride BioChemika 90182  
Trichloroacetic acid Merck 807  
Tris Roth 5429.3  
Triton® X-100 Sigma T9284-100ML  
Trizol® reagent  Invitrogen  15596-018  
Trypsin/EDTA BioChrom L2143  
Trypton Biodeal CH1008,1000  
Tween® 20 Serva 37470  
Urea Fluka 51456  
Xylene cyanole  Sigma X-4126  
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